| A double-blind placebo-controlled parallel trial of soy phytoestrogens in patients with type 2 diabetes and borderline low testosterone levels | A double-blind placebo-controlled parallel trial of soy phytoestrogens in patients with type 2 diabetes and borderline low testosterone levels | ISRCTN90604927 |
| The effect vitamin C supplementation on infertile women with polycystic ovary syndrome | The comparison of the effectiveness of vitamin C supplementation with balance diet, versus Placebo on the Luteinizing hormone, follicle-stimulating hormone, Dehydroepiandrosterone, testosterone, estradiol, progesterone and sex hormone-binding protein in infertile women with polycystic ovary syndrome | IRCT2013030312672N1 |
| A study to find out vitamin D effect on hormones cortisol, estrogen and testosterone and its impact on primary open angle glaucoma | Effect of vitamin D supplementation on serum levels of cortisol, estrogen and testosterone in patients of primary open angle glaucoma - NIL | CTRI/2024/06/069692 |
| Effects of Aromatase Inhibition Versus Testosterone in Older Men With Low Testosterone: Randomized-Controlled Trial. | The Effects of Aromatase Inhibition and Testosterone Replacement in Sex Steroids, Pituitary Hormones, Markers of Bone Turnover, Muscle Strength, and Cognition in Older Men | NCT00104572 |
| Treatment of Peyronie's disease with hyperthermia, vitamin D and testosterone: a pilot randomised controlled trial | | ISRCTN82950322 |
| The effect of L-arginine with vitamin C supplementation on nitrogen balance , body composition, VO2max, serum growth hormone, testosterone and cortisol in male body builders | The effect of L-arginine with vitamin C supplementation on nitrogen balance , body composition, VO2max, serum growth hormone, testosterone and cortisol in male body builders | IRCT20130616013678N28 |
| A Study of 1 8F-FDHT PET/MRIScans in Women With Breast Cancer | [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone PET Imaging In Patients Advanced Breast Cancer | NCT06145399 |
| Acute Vitamin D Supplementation on Testosterone in Females | Effects of Acute Vitamin D Supplementation on Testosterone in Young, Healthy Females: A Pilot Study | NCT06610968 |
| Salivary Testosterone in Men: Diurnal Variation and Post-Prandial Responses | Salivary Testosterone in Men: Diurnal Variation and Post-prandial Responses | NCT04326673 |
| The Acute Effect of Protein or Carbohydrate Intake on Testosterone Levels and Food Intake in Children and Adolescent Boys | Acute Decrease in Serum Testosterone After Glucose and Protein Beverages in Adolescent Males | NCT03412136 |
| Effect of Vitamin D Supplementation on Testosterone Level in Women With Polycystic Ovary Syndrome | Effect of Vitamin D Supplementation on Testosterone Level in Women With Polycystic Ovary Syndrome: A Randomized, Double-blind, Placebo-controlled Trial | NCT06101147 |
| Effect of Progesterone on Testosterone Concentrations and Breast Development in Transwomen | Effect of Progesterone on Testosterone Concentrations and Breast Development in Transwomen | NCT04534881 |
| Effect of Ashwagandha supplementation on testosterone levels and vitality in healthy, overweight men | Effect of Ashwagandha supplementation on testosterone levels and vitality in healthy, overweight males with mild to moderate symptoms of fatigue or reduced vitality – a randomised, double-blind, placebo-controlled study | ACTRN12617000971336 |
| Testosterone Replacement Therapy in Women with Turner Syndrome | Testosterone Replacement Therapy in Women with Turner Syndrome – Endocrine, Cardiovascular, Physiological, Neurocognitive and Genomic effects | CTIS2024-517755-12-00 |
| Evaluating Prevention of Muscle Loss After Menopause Using Testosterone: The PAMELA study | Evaluating prevention of Muscle Loss After Menopause Using Testosterone: The PAMELA study | ACTRN12623000166673 |
| Effect of legume-based DASH diet in patients with polycystic ovary syndrome | The effects of legume-based DASH diet on anthropometric factors, glucose & lipid profiles and testosterone level in women with polycystic ovary syndrome (PCOS): A randomized clinical trial | IRCT20120913010826N33 |
| A Crossover Clinical Trial Investigating the Effects of Geranylgeraniol (GG) Supplementation on Testosterone Levels in Healthy Men and Women Over an 18-week Period | A Crossover Clinical Trial Investigating the Effects of Geranylgeraniol (GG) Supplementation on Testosterone Levels in Healthy Men and Women Over an 18-week Period | NCT06747624 |
| Pharmacokinetics of a Novel Vaginal Delivery System for Testosterone and Dehydroepiandrosterone (DHEA) | Prospective, Randomized, Open-label and Comparative Study to Determine the Pharmacokinetic Parameters of Vaginal Rings That Contain DHEA, Testosterone, or the Combination of Both Androgens, in Comparison With Oral Administration of DHEA and Transdermal Administration of Testosterone, in Postmenopausal Women | NCT03967964 |
| Evaluation of four types of therapies for the treatment of urogenital atrophy in postmenopausal women | Randomized controlled clinical trial, with topical use of estrogen,testosterone, polyacryli cacid and placebo in the treatment of urogenital atrophy in postmenopausal women | RBR-2wjrp4 |
| Single-Dose Pharmacokinetics of Oral Testosterone Undecanoate With and Without Concomitant Inhibition of UGT2B17 | Single-Dose Pharmacokinetics of Oral Testosterone Undecanoate With and Without Concomitant Inhibition of UGT2B17 With Oral Curcumin in Normal Men With Experimental Hypogonadism | NCT06312761 |
| Effect of diet therapy with and without Curcumin in treatment of Polycystic Ovary Syndrome | Investigation of the Effects of DASH and Standard Diets With and Without Curcumin Supplementation on Gene Expression of Interleukin-1 Alpha , 5 Alpha – Reductase, Serum Concentration of Testosterone and Glycemic Indices in Infertile Women With Polycystic Ovary Syndrome Candidate for In Vitro Fertilization (IVF) | IRCT20200915048731N1 |
| Effect of Testosterone Treatment on Drug Metabolism and Transport | Effect of Gender-Affirming Testosterone Therapy on Drug Metabolism, Transport, and Gut Microbiota | NCT05116293 |
| Insulin Sensitivity in Men With the Metabolic Syndrome | Effect of Increasing Testosterone on Insulin Sensitivity in Men With the Metabolic Syndrome | NCT00433173 |
| [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer | [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer | NCT00588185 |
| Artificial intelligence Steering Testosterone deprivation Treatments in prostate cancer External-beam radiotherapy (ASTuTE) | Shared Decision making Using Multimodal Artificial Intelligence (MMAI) with Digital Histopathology for Androgen Deprivation Therapy (ADT) use in men with intermediate risk prostate cancer managed with standard of care radiotherapy | ACTRN12623000713695 |
| Role of Testosterone in Prevention of Alzheimer’s Disease | Role of Testosterone in Prevention of Alzheimer’s Disease | ACTRN12614000277640 |
| A New Hormone Replacement Paradigm: Physiologic Restoration Study | A New Hormone Replacement Paradigm: Physiologic Restoration Using Compounded Biomimetic Estradiol, Progesterone and Testosterone Applied Transdermally in a Rhythmic Dose | NCT04190927 |
| Correlation of Serum Adropin to Testosterone and Adiponectin in Obese Men | Correlation of Serum Adropin to Testosterone and Adiponectin in Obese Men | NCT03724825 |
| Influence of Testosterone Administration on Drug-Induced QT Interval Prolongation and Torsades de Pointes | Influence of Testosterone Administration on Drug-Induced QT Interval Prolongation and Torsades de Pointes | NCT02513940 |
| Effect of Soy on Cognition and Hot Flashes in Men With Prostate Cancer Undergoing Testosterone Suppression Therapy | Effect of Isoflavones on Cognition, Quality of Life and Hot Flashes in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy | NCT00245518 |
| Evaluation of four types of therapies for the prevention of vaginal stenosis in women whit cervical carcinoma after radiation therapy | Randomized clinical trial, whit topical festrogen use, testosterone, therapy and vaginal dilator in the prevention of vaginal stenosis in women whit cervical carcinoma after radiation therapy | RBR-23w5fv |
| 52 Week Study of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism | Open-Label, Multiple-Dose, 52-Week Study to Evaluate the Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Deficiency or Absence of Endogenous Testosterone Due to Primary or Secondary Hypogonadism | NCT06689085 |
| Evaluation of Metabolic and Cardiovascular Risk markers in transgender men using Testosterone | Evaluation of Metabolic, Inflammatory, Cardiovascular and Endothelial Risk markers in transgender men on Testosterone therapy | RBR-8xtsgvv |
| Effect of Moderate Exercise on Serum Testosterone , Cortisol , and C- Reactive Protein (CRP) in young Adults | A study on association of Serum Testosterone , Cortisol , and C-Reactive Protein (CRP) levels with moderate exercise in young adult in North India - NIL | CTRI/2024/11/076953 |
| Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance | Investigating the Effect of Testosterone Replacement Therapy Among Hypogonadal Men With Localized Prostate Cancer on Active Surveillance | NCT06733350 |
| The effect of pretreatment transdermal testosterone gel on in vitro fertilization outcomes in patients with poor ovarian reserve, a randomized controlled trial | The effect of pretreatment transdermal testosterone gel on in vitro fertilization outcomes in patients with poor ovarian reserve, a randomized controlled trial | TCTR20250305004 |
| Effectiveness of Qualia Testosterone Supplementation on Testosterone Levels | Effectiveness of Qualia Testosterone Supplementation on Testosterone Levels: A Randomized Double-Blind Parallel Trial | NCT07028255 |
| Topical Testosterone Replacement in Patient Volunteers with low blood testosterone levels. | A Single-Dose, Single Period, Phase II Pharmacokinetic Study To Examine TDS®-Testosterone For Its Potential To Be Inadvertently Transferred By Skin Contact After Dosing In Healthy Adult Subjects - Testagen™ Transference T1-09-13 | EUCTR2013-001767-23-GB |
| Cycled Testosterone Therapy to Improve Physical Function in Frail Nursing Home Residents | Cycled Testosterone Therapy to Improve Physical Function in Frail Nursing Home Residents | NCT02679274 |
| Intranasal Delivery of Testosterone and Its Effect on Doping Markers | Intranasal Delivery of Testosterone and Its Effect on Doping Markers | NCT02611154 |
| Bioavailability study of a new testosterone orodispersible tablet (ODT) administered as single doses of 6 and 12 mg to healthy postmenopausal women | Bioavailability study of a new testosterone orodispersible tablet (ODT) administered as single doses of 6 and 12 mg to healthy postmenopausal women. Single dose, open, randomised, 3-period, 3-way cross-over exploratory bioavailability study | ISRCTN13049111 |
| A randomized double-blind study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig Cell Insufficiency (Einstein-invervention) | A Randomized double-blind study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig Cell Insufficiency (Einstein-intervention) - EINSTEIN INTERVENTION | EUCTR2015-001452-30-DK |
| Testosterone Gel in Poor Responders Undergoing IVF | Effectiveness of Testosterone Gel Pretreatment in Poor Responders Undergoing IVF Treatment: a Randomized Controlled Trial | NCT02549690 |
| Testosterone Therapy for Pubertal Delay in Duchenne Muscular Dystrophy | Observational Study of Clinical Outcomes for Testosterone Treatment of Pubertal Delay in Duchenne Muscular Dystrophy | NCT02571205 |
| Low-dose testosterone treatment in trans individuals | Effects of Low-Dose Testosterone on Mental and Physical Health Outcomes in Trans Individuals | ACTRN12624001337561 |
| EndogenousTestosterone Response to a Testosterone Boosting Supplement | EndogenousTestosterone Response to a Testosterone Boosting Supplement | NCT02600650 |
| Subcutaneous Testosterone Enanthate Safety in Adult Men Diagnosed With Hypogonadism | A 6-Month Safety Study of QuickShot™ Testosterone Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism | NCT02504541 |
| Testosterone, Metformin, or Both, for Hypogonadism in Obese Males | Randomized, Double-blind, Parallel, Placebo-controlled, Clinical Trial to Assess the Efficacy of Testosterone, Metformin, or Both, for the Treatment of Obesity-induced Male Hypogonadism | NCT02514629 |
| Effects of testosterone and exercise (TEX) on fitness, physical activity and vascular health in men. | Effects of testosterone and exercise (TEX) on fitness, physical activity and vascular health in men aged 50-70 years with waist circumference 95 cm or more: a 2x2 factorial randomised controlled trial. | ACTRN12615000600549 |
| The effects of testosterone gel administration in ART | The effects of testosterone gel administration in the ovarian response to FSH in older women with poor response to traditional methods of assisted reproduction | IRCT201505197513N11 |
| Transdermal Testosterone Nanoemulsion in Women Libido | Transdermal Testosterone Nanoemulsion Effects Emergent Loss of Libido in Women: A Randomized, Double-Blind, Placebo-Controlled Trial | NCT02445716 |
| Comparison of the pharmacokinetic profiles of separately administered sublingual testosterone followed by a sildenafil citrate tablet, versus sublingual testosterone and sildenafil citrate combined in a fixed-dose combination tablet | A randomized, cross-over controlled study to compare the pharmacokinetic profiles of sublingual administered testosterone solution followed by a sildenafil citrate tablet, versus sublingual testosterone and sildenafil citrate combined in one tablet in healthy premenopausal women | ISRCTN14616088 |
| Body Composition in Infants With Klinefelter Syndrome and Effects of Testosterone Treatment | Body Composition in Infants With Klinefelter Syndrome and Effects of Testosterone Treatment | NCT02408445 |
| Effects of Transdermal Testosterone and/or Monthly Vitamin D on Fall Risk in Pre--frail Hypogonadal Seniors | Effects of Transdermal Testosterone and/or Monthly Vitamin D on Fall Risk in Pre--frail Hypogonadal Seniors. Double Blind, 2x2 Factorial, Randomized Placebo--Controlled Clinical Trial | NCT02419105 |
| Evaluate the Pharmacokinetics and Gonadotropin Suppression of Nestorone®-Testosterone (NES/T) Combination Gel in Men | A Randomized, Two Center, Double-Blind Trial to Evaluate the Pharmacokinetics and Gonadotropin Suppression of Nestorone®-Testosterone (NES/T) Combination Gel in Healthy Men | NCT02432261 |
| Testosterone supplementation combined with exercise program to improve muscle condition in men affected by inclusion body myositis. | Testosterone plus exercise to improve muscle strength and performance in men affected by inclusion body myositis (IBM). | ACTRN12618000755235 |
| Testosterone Pellets Plus Vitamin D and E Versus Vitamin D and E Alone for the Treatment of Peyronie's Disease | An Open-Label, Nine-Month Randomized Controlled Study of Testosterone (Testopel) Pellets Plus Vitamin D and E Versus Vitamin D and E Alone for the Treatment of Peyronie's Disease | NCT01578473 |
| Transdermal testosterone gel for poor ovarian responders. A multicenter double-blind placebo controlled randomized trial. | Transdermal testosterone gel for poor ovarian responders. A multicenter double-blind placebo controlled randomized trial. - Testosterone TRANSdermal gel for Poor Ovarian Responders Trial (T-TRANSPORT) | EUCTR2014-001835-35-BE |
| Sexual Well Being After Breast cancer study - SWAB study | Efficacy and safety of intra-vaginal testosterone for the treatment of vulvo-vaginal atrophy (VVA) associated with aromatase inhibitor therapy in women with breast cancer. | ACTRN12615000083594 |
| A clinical trial for the effects of testosterone replacement therapy in male patients with hypogonadism on arterial function markers | Effect of long-term testosterone replacement therapy on arterial stiffness and endothelial function in male patients with hypogonadism | EUCTR2014-005179-10-GR |
| Testosterone Therapy in Hypogonadal Men Treated With Opioids | The Effect of Testosterone Replacement in Patients With Hypogonadotrophic Hypogonadism Due to Opioid Treatment for Non-malignant Disease | NCT02433730 |
| Puberty, Testosterone, and Brain Development | Effect of Testosterone on Brain Imaging and Headache in Transmasculine Adolescents | NCT06670053 |
| Effect Of Testosterone Supplements On Anemia And Quality Of Life Amongst Patients On Regular Hemodialysis | Effect Of Testosterone Replacement On Anemia And Quality Of Life Amongst Patients On Maintenance Hemodialysis | ACTRN12624001137583 |
| Analysis of the correlation between stress urinary incontinence in postmenopausal women and serum testosterone and its precursors. | Analysis of the correlation between stress urinary incontinence in postmenopausal women and serum testosterone and its precursors. | ChiCTR2300078752 |
| Study of Testosterone vs Placebo in Testicular Cancer Survivors | A Randomized Double-blind Study of Testosterone Replacement Therapy or Placebo in Testicular Cancer Survivors With Mild Leydig Cell Insufficiency (Einstein-intervention) | NCT02991209 |
| Study of Serum Testosterone and Nestorone in Females After Secondary Exposure to Nestorone ® (NES) + Testosterone (T) Combined Gel Applied to Shoulders and Upper Arms in Males | An Open-Label Study of Serum Testosterone and Nestorone in Females After Secondary Exposure to Nestorone ® (NES) + Testosterone (T) Combined Gel Applied to Shoulders and Upper Arms in Males: Effect of Washing or Clothing Barrier to the Application | NCT02994602 |
| The efficacy of testosterone gel application for increases the sperm concentration in infertile men with oligospermia and low serum testosterone level | The efficacy of testosterone gel application for increases the sperm concentration in infertile men with oligospermia and low serum testosterone level | TCTR20161030001 |
| Open-Label Study, Evaluating Patient Satisfaction and Symptom Improvement When Treating Male Hypogonadism With Natesto™ | A 150-Day, Prospective, Phase 4, Open-Label Study, Evaluating Patient Satisfaction and Symptom Improvement When Treating Male Hypogonadism With Testosterone Nasal Gel (Natesto™) | NCT02937740 |
| Starting a Testosterone and Exercise Program After Hip Injury | Combining Testosterone Therapy and Exercise to Improve Function Post Hip Fracture | NCT02938923 |
| The Effect of Various Amounts of Fat on PK of Oral Testosterone Undecanoate | A Phase 2 Study of the Effect of Meals With Various Amounts of Fat Given Immediately After Dosing on the Pharmacokinetics of an Oral Testosterone Undecanoate | NCT02921386 |
| Study to Compare DITEST to Testosterone Undecanoate in Adult Men With Hypogonadism | A Phase 1, Randomised, Open-label, 2-cohort, Cross-over Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Native Oral Testosterone Formulation (DITEST) in the Fed and Fasted State and Compared to Testosterone Undecanoate in Adult Men With Primary or Secondary Hypogonadism | NCT02966652 |
| A Novel Liver Targeted Testosterone Therapy for Sarcopenia in Androgen Deprived Men with Prostate Cancer - A Blinded Randomized Controlled Trial | A Novel Liver Targeted Testosterone Therapy for Sarcopenia in Androgen Deprived Men with Prostate Cancer - A Blinded Randomized Controlled Trial | ACTRN12616001166460 |
| Estradiol and Testosterone Subdermal Implants for Menopause Treatment (ESTIME) | Pharmacokinetic, Clinical, Hormonal and Therapeutic Effects of the Use of Estradiol and Testosterone Hormonal Subdermal Implants in Women With Natural Menopause, Premature Ovarian Failure or Surgical Menopause Due to Cervical Cancer. | NCT06343870 |
| Effect of PROGRESSive Training and Teststerone in Older Frail Men | Effect of PROGRESSive Resistance Training, Protein Supplements and Testosterone in Older Frail Men With Testosterone Deficiency (PROGRESS Trial) | NCT02873559 |
| Testosterone treatment in men with liver disease | Effect of Testosterone Treatment on Mortality and Hospitalisation in Men with Liver Cirrhosis and low serum testosterone: A Randomized Controlled Trial | ACTRN12616000756426 |
| Effect of Testosterone Replacement on Exercise Capacity in Hypogonadal Men After a Recent Myocardial Infarction | Effect of Testosterone Replacement on Exercise Capacity in Hypogonadal Men After A Recent Myocardial Infarction. | NCT02803073 |
| Alterations in Body Fat and Composition among Thai Transgender Men Undergoing Short-term Testosterone Therapy | Alterations in Body Fat and Composition among Thai Transgender Men Undergoing Short-term Testosterone Therapy | TCTR20241004001 |
| Safety of Subcutaneous Testosterone Enanthate in Adult Male Hypogonadism | An Open-Label Study to Evaluate the Safety of Testosterone Enanthate After Two Single-Dose Injections Via QuickShot® Testosterone by Intended Users and QuickShot™ Summative Usability Study | NCT02777242 |
| Cardiovascular Outcomes of Low Testosterone | Cardiovascular Consequences of Hypogonadism in Men | NCT02758431 |
| Physiological and Psychological Effects of Testosterone During Severe Energy Deficit and Recovery | Physiological and Psychological Effects of Testosterone During Severe Energy Deficit and Recovery: a Randomized, Placebo Controlled Trial | NCT02734238 |
| Testosterone Replacement in Renal Failure | Effect of Testosterone Replacement on Erythropoietin Stimulating Agent Use in End Stage Renal Disease Patients | NCT02712944 |
| Testosterone treatment for the management of fatigue in ambulatory patients with advanced cancer: A pilot feasibility double-blind placebo-controlled study | Testosterone treatment for the management of fatigue in ambulatory patients with advanced cancer: A pilot feasibility double-blind placebo-controlled study | ACTRN12624000345583 |
| A Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men | A Phase 3, Randomized, Active-controlled, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU) in Hypogonadal Men | NCT02722278 |
| Comparing Direct and Indirect Detection Methods of Multiple Routes of Testosterone Administration | Comparing Direct and Indirect Detection Methods Following Multiple Routes of Testosterone administration-an Anti-doping Perspective | NCT06393634 |
| Efficacy, Safety, and Tolerability of Argin ED in the Treatment of Erectile Dysfunction in Elderly Diabetic Patients | An Open Label, Prospective, Randomized, Three Arm Parallel Study to Compare the Clinical Efficacy, Safety, and Tolerability of L Arginine plus Fenugreek, Tadalafil plus L Arginine Plus Fenugreek, and Tadalafil plus Testosterone in the Treatment of Erectile Dysfunction in Elderly Diabetic Patients - NIL | CTRI/2024/05/067557 |
| The Effects of Semaglutide vs Testosterone Replacement Therapy on Functional Hypogonadism and Sperm Quality in Men With Type 2 Diabetes Mellitus and Obesity | The Effects of Semaglutide vs Testosterone Replacement Therapy on Functional Hypogonadism and Sperm Quality in Men With Type 2 Diabetes Mellitus and Obesity | NCT06489457 |
| Phlebotomy Study of Testosterone Undecanoate | Evaluation of Blood Collection Methodology Following Administration of a Single-Dose of an Oral Testosterone Undecanoate Formulation In Hypogonadal Men | NCT02670343 |
| Pharmacokinetics, Pharmacodinamic and Safety of Testosterone Gel 1% | Phase I Clinical Trial for Evaluation of Pharmacokinetics, Pharmacodynamics and Safety of Testosterone Gel 1% for Topical Use, After Administration of Three Different Doses (2.2 mg, 4.4 mg, 8.8 mg and Placebo) for 28 Consecutive Days in Post-menopausal Women. | NCT02667561 |
| Effect of Testosterone treatment on fatty liver in Type 2 diabetic men having low testosterone levels. | Effect of Testosterone Therapy on Indices of MASLD in Men With Type 2 Diabetes Mellitus Having Low Testosterone Levels. - NIL | CTRI/2024/06/069304 |
| TESTO-TRIAL: Use of Testosterone in Critically Ill Patients | TESTO-TRIAL: Randomized Clinical Trial on the Use of Testosterone in Critically Ill Patients | NCT06592144 |
| Muscle strength and -mass after bariatric surgery - a possible effect of testosterone replacement therapy?Randomized, placebo-controlled and double-blinded study | Muscle strength and -mass after bariatric surgery - a possible effect of testosterone replacement therapy?Randomized, placebo-controlled and double-blinded study | CTIS2024-517015-73-00 |
| Effects of testosterone on urea metabolism in men with hypogonadism | Effects of testosterone on urea metabolism in men with hypogonadism | ACTRN12616000577415 |
| Testosterone for Androgen Deficiency-Like Symptoms | Testosterone for Androgen Deficiency-Like Symptoms: A three phase, placebo-controlled, double-blind crossover study for males 40 years or older who believe they have androgen-like deficiency to assess whether testosterone gel treatment is superior to a placebo gel. | ACTRN12615000071527 |
| Pharmacokinetics of Testosterone Cream Applied to Scrotal Skin in healthy male volunteers | Pharmacokinetics of Testosterone Cream Applied to Scrotal Skin in healthy male volunteers | ACTRN12615000045516 |
| DETECTION OF CONSUMPTION OF TESTOSTERONE GEL IN SPORT. | Establishment of an Athlete's Internal Metabolic Reference Using an Isotopic Signature or Isotopic Fingerprint of ?13C Values - testgel | EUCTR2014-001655-23-ES |
| Evaluation of Testosterone therapy in Heart Failure | Beneficial effects of Testosterone therapy on functional capacity, cardiovascular parameters, and quality of life in patients with Congestive Heart Failure | IRCT2013070113828N1 |
| Metabolomics During Testosterone Therapy | Testosterone Therapy and Its Effects on Metabolic Function | NCT01963390 |
| Transdermal Testosterone Pretreatment in Poor Responders Undergoing IVF | The Effect of Transdermal Testosterone Pretreatment in Poor Responders Undergoing Ovarian Stimulation for In-vitro Fertilization (IVF) | NCT01961336 |
| A Dose Ranging Study to Examine TDS-Testosterone 5% | A Multiple-Dose, Single Period, Phase II Dose Ranging Study to Examine TDS-Testosterone 5% in Adult Male Subjects | NCT01894308 |
| The Effect of Testosterone Topical Solution (LY900011) in Hypogonadal Men With Suboptimal Response to a Topical Testosterone Gel | The Effect of Testosterone Topical Solution (LY900011) in Hypogonadal Men With Suboptimal Response to a Topical Testosterone Gel | NCT01893281 |
| Effect of Testosterone Therapy Combined with Very Low Caloric Diet on Weight Loss and Weight Maintenance in Obese Men: A Randomized Controlled Trial | Effect of Testosterone Therapy Combined with Very Low Caloric Diet on Weight Loss and Weight Maintenance in Obese Men: A Randomized Controlled Trial | ACTRN12613000613707 |
| Testosterone Replacement for Male Opioid Agonist Maintained Patients | Testosterone Replacement for Male Opioid Agonist Maintained Patients | NCT01873989 |
| Exercise Training and Testosterone Replacement in Heart Failure Patients | Exercise Training and Testosterone Replacement in Heart Failure Patients | NCT01852994 |
| A study in men with low testosterone to measure the effect of testosterone solution on testosterone levels, sex drive and energy. | A Randomized, Double-Blind, Placebo-Controlled Parallel Study with an Open-Label Extension to Assess the Impact of Testosterone Solution on Total Testosterone, Sex Drive and Energy in Hypogonadal Men. | EUCTR2012-004866-16-DE |
| Testosterone Antidepressant Augmentation in Women | Collaborative Study: Testosterone Antidepressant Augmentation in Women | NCT01783574 |
| A Research Study of Injections of Testosterone in an Oil Vehicle for men with Androgen Deficiency: Reandron (Testosterone Undecanoate) will be administered subcutaneously and intramuscularly. | Pharmacokinetics of Subcutaneous Injection of Testosterone in an Oil Vehicle: A Randomised crossover study of Reandron (Testosterone Undecanoate) given subcutaneously and intramuscularly in hypogonadal men. | ACTRN12613000101785 |
| Intervention of Testosterone & Fish Oil as a possible strategy for the Prevention of Alzheimer’s Disease | A 56 week, double-blind, randomised, placebo-controlled trial to determine the efficacy of testosterone, with and without DHA supplementation in PiB positive men with Subjective Memory Complaints as a strategy to prevent the development of Alzheimer’s Disease. | ACTRN12613000034730 |
| Safety and Efficacy Trial of Testosterone Undecanoate | Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men | NCT01765179 |
| Short-term effects of two drugs containing testosterone on neuro-physiological function | Short-term effects of testosterone enhantate and gel on neuro-physiological function | EUCTR2013-001734-17-IT |
| Testosterone Replacement in men with liver disease | Pilot open study of testosterone replacement in non-alcoholic steatohepatitis - TEREPINS: Testosterone Replacement in Non-alcoholic Steatohepatitis | EUCTR2012-002564-27-GB |
| A Study of Effect of Deodorant and Axillary Hair on Testosterone Absorption in Healthy Participants | Effects of Deodorant and Antiperspirant Use and the Presence of Axillary Hair on the Absorption of Testosterone Applied as Testosterone 2% Solution | NCT01725451 |
| Effectiveness of Testosterone Undecanoate to Improve Sexual Function in Postmenopausal Women | Effectiveness of Testosterone Undecanoate to Improve Sexual Function in Postmenopausal Women | NCT01724658 |
| A Multicenter Extension Trial to Evaluate the Safety of Testosterone Gel | A Multicenter Extension Trial to Evaluate the Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males | NCT01703741 |
| Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: The Effects of Vaginal Testosterone Therapy | Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: A Pilot Study on the Effects of Vaginal Testosterone Therapy | NCT01697345 |
| Evalation of the effects of testosterone undecanoate, metformin, or a combination of both, for the treatment of decreased testicular function and erectile dysfunction in obese males | RANDOMIZED CLINICAL TRIAL TO ASSESS THE EFFICACY OF TESTOSTERONE UNDECANOATE, METFORMIN, OR THE COMBINATION OF BOTH, FOR THE TREATMENT OF ISOLATED HYPOGONADOTROPIC HYPOGONADISM AND ERECTILE DYSFUNCTION IN OBESE MALES | EUCTR2012-000870-51-ES |
| T-IR- Study to Understand the Effects of Testosterone and Estrogen on the Body's Response to the Hormone Insulin | Androgen-mediated Pathways in the Regulation of Insulin Sensitivity in Men | NCT01686828 |
| Testosterone and Pain Sensitivity | Effects of Testosterone Replacement on Pain Sensitivity and Pain Perception in Men With Chronic Pain Syndrome | NCT01689896 |
| Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men | Open-Label Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men | NCT01699178 |
| Effect of treatment with testosterone in diabetic patients (Type 1) with hypogonadism. | Effect of treatment with testosterone undecaonat in patients with Diabetes Mellitus Type 1 (DM-1) and hipogonadotrophic hypogonadism | EUCTR2012-000291-42-ES |
| A study to investigate the subjective and fysiological effects of the combined administration of testosterone and buspirone and buspirone administration alone in women with decreased sexual desire | A double-blind, randomized, placebo-controlled, proof of concept study to investigate the differences between the combined administration of 0.5 mg sublingual testosterone and 10 mg buspirone and 10 mg buspirone administration alone in women with hypoactive sexual desire disorder - EB93 PoC | EUCTR2012-003543-30-NL |
| Effect of Testosterone Treatment on Embryo Quality | A Randomized Double Blind Control Trial of Transdermal Testosterone Supplementation vs Placebo on Follicular Development and Atresia, Oocyte and Embryo Quality Among Women With Diminished Ovarian Reserve Undergoing in Vitro Fertilization | NCT01662466 |
| A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel | A Phase 3, Open-label, Non-randomized, Clinical Trial to Evaluate the Efficacy and Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males | NCT01665599 |
| Comparison Between Testosterone and Estradiol Over the Homogenization of Follicular Cohort | Comparison Between Testosterone and Estradiol Over the Homogenization of Follicular Cohort: a Randomized Clinical Trial | NCT03238092 |
| Testosterone Undecanoate and Quality of Life of Men and Spouses | Satisfaction and Quality of Life of Men and Spouses of Hypogonadal Men Treated With Injectable Testosterone Undecanoate | NCT01758029 |
| Head Injury and Testosterone | A 12-month, double-blind, randomised, placebo-controlled clinical trial to determine the efficacy of multiple-dose testosterone undecanoate administration on neuropsychological, psychosocial and biological markers (biomarkers) in male participants with traumatic brain injury. | ACTRN12613001219774 |
| Impact of consumption of testosterone in the steroid profile in athletic population | Clinical Trial crossed athletic population according UGT2B17 polymorphism. Impact on the steroid profile - ECDOPDEP2013 | EUCTR2013-005135-24-ES |
| Pilot Pharmacokinetic Study of Oral Testosterone Ester Formulations in Hypogonadal Men | Phase IIa, Pilot, Pharmacokinetic Study of Oral Testosterone Ester Formulations in Hypogonadal Men | NCT02697188 |
| Testosterone and exposure therapy for SAD | Enhancement of exposure therapy for social anxiety disorder with testosterone: A randomized clinical trial | EUCTR2014-004475-23-NL |
| Enhancement of exposure therapy for social anxiety disorder with testosterone: A randomized placebo controlled clinical trial | Enhancement of exposure therapy for social anxiety disorder with testosterone: A randomized placebo controlled clinical trial - Testosterone enhancement of exposure therapy in SAD | NL-OMON44812 |
| Peri-Operative Testosterone Administration in Primary Hip Arthroscopy | Peri-Operative Testosterone Administration in Primary Hip Arthroscopy | NCT06462482 |
| Peri-Operative Testosterone Administration in Primary Total Hip Arthroplasty | Peri-Operative Testosterone Administration in Primary Total Hip Arthroplasty | NCT06608914 |
| TRT in Combination With Electrical Stimulation and Standing: Effect on Muscle and Bone in Spinal Cord Injured Males | Testosterone Replacement Therapy in Combination With Electrical Stimulation and Standing: Effect on Muscle and Bone in Spinal Cord Injured Males. | NCT02317640 |
| A Trial to Investigate the Effectiveness of Testosterone Treatment in Men With Multiple Sclerosis | | NCT02317263 |
| The role of testosterone in value-based decision making - An exploratory investigation into the effects of testosterone on choice behavior and its underlying psychological processes | The role of testosterone in value-based decision making - An exploratory investigation into the effects of testosterone on choice behavior and its underlying psychological processes - Testosterone and decision making | NL-OMON40950 |
| Effects of Fast Acting Testosterone Nasal Spray on Anxiety | Effects of Fast Acting Testosterone Nasal Spray on Anxiety | NCT02361190 |
| [18F] Dihydro-testosterone Pet and MR Imaging In Patients With Localized Prostate Cancer | Phase I Trial Of [18F] Dihydro-testosterone Pet and MR Imaging In Patients With Localized Prostate Cancer | NCT02297386 |
| Testosterone Revival Abolishes Negative Symptoms, Fosters Objective Response and Modulates Enzalutamide Resistance | A Randomized Phase II Study Comparing Bipolar Androgen Therapy vs. Enzalutamide in Asymptomatic Men With Castration Resistant Metastatic Prostate Cancer | NCT02286921 |
| A double-blind, randomised, placebo-controlled study to evaluate the effect of an orally-dosed herbal formulation containing Testofen, on sexual function, performance, and serum testosterone levels in healthy males. | A double-blind, randomised, placebo-controlled study to evaluate the effect of an orally-dosed herbal formulation containing Testofen, on sexual function, performance, and serum testosterone levels in healthy males. | ACTRN12611000830998 |
| Testosterone Regulation of the Natriuretic Peptide System | Testosterone Regulation of the Natriuretic Peptide System | NCT02269072 |
| How androgens exert their anabolic effects: effects of oral testosterone on protein metabolism in healthy men. | How androgens exert their anabolic effects. Effects of oral testosterone on protein metabolism in healthy men. | ACTRN12614001045606 |
| Testosterone Plus Finasteride Treatment After Spinal Cord Injury | Higher-Than-Replacement Testosterone Plus Finasteride Treatment After SCI | NCT02248701 |
| An open-label, phase 2, single centre, randomised, crossover pharmacokinetic study assessing two application areas of 0.5ml (5mg) of a testosterone 1% cream, ANDROFEME(Registered trademark) in healthy postmenopausal women | An open-label, phase 2, single centre, randomised, crossover pharmacokinetic study assessing two application areas of 0.5ml (5mg) testosterone 1% cream, ANDROFEME(Registered trademark) in healthy postmenopausal women | ACTRN12614000962639 |
| Pharmacokinetic Study of Subcutaneous Testosterone Enanthate | An Open-Label Study to Evaluate the Pharmacokinetics of Testosterone Enanthate After Single-Dose Injection Via QuickShot® Testosterone in Healthy Male Subjects | NCT02233751 |
| Subcutaneous Testosterone Project | A Pilot Study of Subcutaneous vs. Intramuscular Testosterone for Gender Affirming Therapy | NCT02229617 |
| Safety Study of Transdermal Testosterone for Low Libido in Pre and Postmenopausal Women | Phase 2 Study of Transdermal Testosterone for Low Libido in Pre and Postmenopausal Women | NCT02215434 |
| Aggressive Impulse Management (testosterone administration) | Aggressive Impulse Management (testosterone administration) - Aggressive Impulse Management (testosterone administration) | NL-OMON40794 |
| Endothelial Dysfunction, Inflammation and Insulin Resistance in Congenital Hypogonadism and Effect of Testosteron Replacement Therapy | Phase 4 Study That Evaluates the Presence of Endothelial Dysfunction, Inflammation and Insulin Resistance in Male Subjects With Hypogonadotrophic Hypogonadism and Effects of Two Different Testosterone Replacement Regiments on These Parameters. | NCT02171390 |
| Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism | A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism | NCT02159469 |
| The safety and effectiveness of testosterone pellet implantation in hypogonadal males | An Open-Label Study to Characterize the Pharmacokinetics, Effectiveness, and Safety of Subcutaneous Implantation of 12 Testosterone Pellets (AA3000 75mg) in Hypogonadal Males | ACTRN12614000604606 |
| The Impact of Low Testosterone Levels on Men with Liver Failure, and the Efficacy of Testosterone Therapy | A randomised, double-blinded trial in men with cirrhosis of Testosterone therapy versus placebo to assess the impact on body composition | ACTRN12614000526673 |
| A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males | A Phase 3, Open-Label, Non-Randomized, Clinical Trial to Evaluate the Efficacy and Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males | NCT02149264 |
| A Randomized, Double-Blind, Placebo-Controlled Parallel Study with an Open-Label Extension to Assess the Impact of Testosterone Solution on Total Testosterone, Sex Drive and Energy in Hypogonadal Men | A Randomized, Double-Blind, Placebo-Controlled Parallel Study with an Open-Label Extension to Assess the Impact of Testosterone Solution on Total Testosterone, Sex Drive and Energy in Hypogonadal Men | KCT0001108 |
| Diagnostic Relevance of Salivary Testosterone Concentrations in Doping Control. | Diagnostic Relevance of Salivary Testosterone Concentrations After Exogene Low-dose Hormone Application as a Screening Method for in Doping Control. | NCT02134470 |
| Bioequivalence Study of Test and Reference Testosterone Topical Gel, 1.62% Metered Pump in Testosterone Deficient Adult Male Subjects Under Fasting Conditions | An Open-Label, Randomized, Balanced, Single-Dose, Two Treatment, Four Period, Two Sequence Replicate Design, Bioequivalence Study Of Testosterone Topical Gel, 1.62% Metered Pump, Manufactured By Amneal Pharmaceuticals LLC With AndroGel (Testosterone Gel) 1.62% Metered-Dose Pump, Marketed By Abbvie Inc., In Testosterone-Deficient (Hypogonadal) Adult Male Subjects Under Fasting Conditions | NCT02110368 |
| RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistance (The RESTORE Study) | A Phase II Study to Determine Sequential Response to Bipolar Androgen Therapy (BAT) Followed by Enzalutamide or Abiraterone Post-BAT in Men With Prostate Cancer Progressing on Combined Androgen Ablative Therapies | NCT02090114 |
| Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism | Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men | NCT02081300 |
| The impact of endogenous testosterone for gender differences in pain, sensory perception and therapy of pain | The impact of endogenous testosterone for gender differences in pain, sensory perception and therapy of pain - TestoSense | DRKS00010854 |
| Resistance Training and Testosterone After Spinal Cord Injury | Effects of Evoked Resistance Training and Testosterone After Spinal Cord Injury | NCT01652040 |
| Testosterone-induced Muscle Memory and Underlying Mechanisms | Long-term Effects of Anabolic Androgenic Steroids on Muscle Growth Potential: Testosterone-induced Muscle Memory and Underlying Mechanisms | NCT06188767 |
| The Anabolic Effect of Testosterone on Pelvic Floor Muscles | A Pilot Study to Evaluate the Anabolic Effect of Testosterone on Muscles of the Pelvic Floor in Older Women With Stress Urinary Incontinence | NCT06111209 |
| Testosterone Implants and the Incidence of Breast Cancer | Testosterone Implants and the Incidence of Breast Cancer RETROSPECTIVE CHART REVIEW | NCT03768258 |
| "Study on Effects of Testosterone Replacement Therapy in Hypogonadal Type 2 Diabetic Patients"" (SETH2)" | Study on Effects of Testosterone Replacement Therapy in Hypogonadal Type 2 | NCT03792321 |
| A study to evaluate the efficacy of Investigational Drug M. Libido, in Enhancing Testosterone Level and Improving Sperm Profile in Male Volunteers | A Prospective, Double Blinded, Randomized, Comparative Study to Evaluate the Efficacy of Investigational Drug M. Libido, in Enhancing Testosterone Level and Improving Sperm Profile in Male Volunteers. - Male Libido | CTRI/2019/01/016876 |
| What effect does testosterone gel have on female steroid levels? | Establishment of the female steroid profile and impact of transdermal testosterone administration on the steroidal metabolism: open-label trial | ISRCTN10122130 |
| The effect of resistance exercise on serum testosterone levels in middle aged men | Study of the effect of resistance exercise on serum testosterone levels, severity signs of aging and quality of life in middle-aged men with late-onset hypogonadism | IRCT20190105042244N1 |
| Comparing Subcutaneous Testosterone to Intramuscular Testosterone in Gender Affirming Care of Transgender Male Adolescents | Investigating the Efficacy of Subcutaneous Testosterone Compared to Intramuscular Testosterone in Gender Affirming Care of Transgender Male Adolescents | NCT03864913 |
| Testosterone Therapy and Bone Quality in Men With Diabetes and Hypogonadism | Testosterone Therapy and Bone Quality in Men With Diabetes and Hypogonadism | NCT03887936 |
| TOTEM RRMS : TestOsterone TreatmEnt on Neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis | TOTEM RRMS : TestOsterone TreatmEnt on Neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis | NCT03910738 |
| TestOsterone TreatmEnt in Relapsing Remitting Multiple Sclerosis | TestOsterone TreatmEnt on neuroprotection and Myelin repair in Relapsing Remitting Multiple Sclerosis - TOTEM-RRMS | EUCTR2018-002648-10-FR |
| Detection of Testosterone Microdosing in Women | Detection of Testosterone Microdosing in Women | ACTRN12619000633189 |
| Testosterone therapy for the treatment of nonalcoholic fatty liver disease | A randomised controlled trial of Testosterone Undecanoate therapy for the treatment of non-alcoholic fatty liver disease (TNT) | ACTRN12619000701123 |
| Testosterone Therapy in Type 2 Diabetes Mellitus Patients with Erectile Dysfunction | Effects of Testosterone Therapy on Erectile Dysfunction in Type 2 Diabetes Mellitus Patients with normal level of Testosterone | IRCT20181106041575N1 |
| Assessment of Blood From Men Receiving Oral TU in Various Collection Tubes | A Study to Assess Post-collection Conversion of Testosterone Undecanoate (TU) to Testosterone in Blood From Men Receiving Oral TU Collected Into Different Types of Sample Tubes | NCT03973840 |
| Studying the effects of intramuscular testosterone supplementation compared with placebo on liver fat content in obese men with low testosterone levels and type 2 diabetes (T2DM) or prediabetes followed by a subsequent open label phase to investigate metabolic long term effects. | A 52 week prospective randomized controlled study to investigate the effect of intramuscular testosterone undecanoate supplementation vs placebo on intrahepatic fat content in overweight/obese men with type 2 diabetes (T2DM) or prediabetes suffering from hypogonadism with a subsequent 108 week open label phase to investigate long term effects on lipid distribution and cardiometabolic parameters in all participating men. - Test2Func | EUCTR2017-001611-37-AT |
| Efficacy and Safety of Testosterone Therapy in Improving Sarcopenia in Men With Cirrhosis. | Efficacy and Safety of Testosterone Therapy in Improving Sarcopenia in Men With Cirrhosis a Randomized Controlled Trial | NCT03995251 |
| Does Testosterone Therapy Improve Patient-Reported Outcomes in Age-Related Testosterone Deficient Patients Undergoing Total Hip Replacement: A Randomized-Controlled Trial | Does Testosterone Therapy Improve Patient-Reported Outcomes in Age-Related Testosterone Deficient Patients Undergoing Total Hip Replacement: A Randomized-Controlled Trial | NCT05722301 |
| Use of transdermal Testosterone in women with decreased sexual desire and tendency for aggressiveness: a double blind randomized clinical trial | Use of transdermal Testosterone Nanoemulsion in women with Hypoactive sexual desire and tendency for aggressiveness: a double blind randomized clinical trial | RBR-27cqn5 |
| Study of effects of testosterone replacement therapy in hypogonadal men with type 2 diabetes mellitus | The Effects Of Testosterone Replacement Therapy On Sexual Functions And Cardiovascular Risk Factors In Hypogonadal Men With Type 2 Diabetes | CTRI/2019/09/021175 |
| Trial of Testosterone Undecanoate for Optimizing Performance During Military Operations | A Randomized, Double-blind, Placebo Controlled Trial of Testosterone Undecanoate for Optimizing Physical and Cognitive Performance During Military Operations (OPS II) | NCT04120363 |
| Use of testosterone cream applied to skin in women with hypoactive sexual desire and quality of life | Transdermal use of testosterone nanoemulsion in women with desire hypoactive sex disorder and quality of life: a double-blind randomized clinical trial | RBR-7sx64c |
| Detection of Testosterone Microdosing in Healthy Men | Detection of Testosterone Microdosing in Healthy Men with an emphasis on profiling effect of the WADA’s Athletes Biological Passport (ABP) | ACTRN12619001506189 |
| Testosterone to treat men with painful osteoarthritis of the knee | A randomised, double-blind, placebo-controlled, parallel group study to determine whether Testosterone treatment on a background of exercise improves physical function, pain and body composition in men with OsteoArthritis of the Knee (TEX-OAK) | ACTRN12619001691134 |
| Generation of Biological Samples Positive to Testosterone for Anti-doping Control | Generation of Biological Samples Positive to Testosterone for Anti-doping Control | NCT04207684 |
| The therapeutic effect of testosterone on lipid profile in patients with chronic kidney disease | The therapeutic effect of testosterone on lipid profile in patients with chronic kidney disease and low testestrone level | IRCT20191009045044N1 |
| Coronary Atherosclerosis Progression with Testosterone InterVEntion (CAPTIVE) | Coronary Atherosclerosis Progression with Testosterone InterVEntion (CAPTIVE): a randomised double blind placebo-controlled non-inferiority trial in middle-aged to older men. | ACTRN12620000100998 |
| Phase II / III clinical study on the efficacy and safety of recombinant human erythropoietin combined with retinoic acid and testosterone undecanoate in the treatment of anemia in patients with relatively low-risk myelodysplastic syndrome | Phase II / III clinical study on the efficacy and safety of recombinant human erythropoietin combined with retinoic acid and testosterone undecanoate in the treatment of anemia in patients with relatively low-risk myelodysplastic syndrome | ChiCTR2000030594 |
| Testosterone to treat men with mild to moderate Crohn's disease | The effect of Testosterone treatment on disease activity and symptoms in men with mild to moderate Crohn’s disease | ACTRN12620000338965 |
| Effect of Testosterone Treatment on Clitoral Arteries' Hemodynamic Parameters. | Pilot Retrospective Study on the Effect of Testosterone Treatment on Clitoral Arteries' Hemodynamic Parameters. | NCT04336891 |
| Testosterone Replacement in Male Cancer Survivors with Fatigue and Low Testosterone | Improving Patient-Important Outcomes with Testosterone Replacement in Hypogonadal Men with a Prior History of Cancer | NCT04049331 |
| Can Testosterone Accelerate Injury Recovery After Arthroscopic Rotator Cuff Repair | A Randomized, Blinded Controlled Trial to Determine if Testosterone Can Accelerate Injury Recovery After Arthroscopic Rotator Cuff Repair | NCT04345666 |
| Testosterone Therapy in Castration Resistant Prostate Cancer | Square Wave Testosterone Therapy in Castration Resistant Prostate Cancer | NCT03734653 |
| Cycled Testosterone Administration During Pulmonary Rehabilitation in Early Stage COPD | Cycled Testosterone Administration During Pulmonary Rehabilitation in Early Stage COPD | NCT03674320 |
| A Single Dose Trial to Evaluate the Pharmacokinetics of Testosterone and Anastrozole | A Single Dose Trial to Evaluate the Pharmacokinetics of Testosterone and Anastrozole From Subcutaneous Testosterone and Anastrozole (T+Ai) in Premenopausal Women | NCT03314298 |
| Long-term Lifestyle Change and Testosterone Replacement | Long-term Lifestyle Change in Obese Older Veterans | NCT03256292 |
| Short-term Testosterone replacement in testicular cancer survivors to treat overweight and improve cardiometabolic risk | Short-term Testosterone replacement in testicular cancer survivors to treat overweight and improve cardiometabolic risk - Short-term Testosterone Replacement in Testicular Cancer Survivors | EUCTR2015-004430-96-NL |
| Effects of Testosterone and Fat Utilization | Testosterone Effects on Systemic Lipolysis and Whole Body Lipid Utilization | NCT03289559 |
| Bioavailability study of a new testosterone tablet formulation administered as single doses of 1, 2 and 3 mg to healthy postmenopausal women | Bioavailability study of a new testosterone tablet formulation administered as single doses of 1, 2 and 3 mg to healthy postmenopausal women | ISRCTN46559299 |
| Evaluation of Testosterone Nasal Gel in Hypogonadal Boys | A Multicenter, Open Label, Variable Dose, Two Arm Pilot Paediatric Phase 1 PK Study to Evaluate Testosterone Nasal Gel (4.5% w/w) in Hypogonadal Boys | NCT03345797 |
| Does Testposterone improve the Pain Perception of Patients with Chronic Pain? | Evaluation of the Therapeutic Effects of Testosterone on Pain Perception in case of Chronic Pain Disorder | EUCTR2016-000048-32-DE |
| Administration study of percutaneous absorption type testosterone to healthy adult males | Administration study of percutaneous absorption type testosterone to healthy adult males | JPRN-jRCT1080223675 |
| Comparative pharmacokinetics and pharmcodynamics of recombinant and urinary human chorionic gonadotrophin (rhCG vs uhCG) | A two part study to compare the pharmacological effects of recombinant human chorionic gonadotrophin (rhCG/Ovidrel) versus urinary human chorionic gonadotrophin (uhCG/Pregnyl) given as subcutaneous injection to healthy men following supression of endogenous testosterone (T) and luteinising hormone (LH) with nandrolone decanoate(ND). | ACTRN12609000462280 |
| Testosterone in Metastatic Renal Cell Carcinoma Patients | Phase 2 Randomized Study of Efficacy and Safety of Testosterone in Metastatic Renal Cell Carcinoma Patients With Fatigue | NCT03379012 |
| Role of testosterone supplementation in poor responders on IVF outcome | Role of transdermal Testosterone gel pretreatment in poor responders on IVF outcome- A prospective randomised controlled trial with active control | CTRI/2017/10/010113 |
| TESTO: Testosterone Effects on Short-Term Outcomes in Infants With XXY | TESTO: Testosterone Effects on Short-Term Outcomes in Infants With XXY | NCT03325647 |
| Effect of injection testosterone on obesity, diabetes, hypertension parameters in patients of hypogonadism | Prevalence of metabolic syndrome and effect of testosterone replacement on metabolic syndrome parameters in a cohort of hypogonadism | CTRI/2017/11/010431 |
| Noninferior crossover study to evaluate blood testosterone improvement using new testosterone gel. | Noninferior crossover study to evaluate blood testosterone improvement using new testosterone gel. - The study to evaluate blood testosterone improvement using new testosterone gel. | JPRN-UMIN000034704 |
| Testosterone and Long Pulse Stimulation After SCI | Testosterone and Long Pulse Width Stimulation for Denervated Muscles After Spinal Cord Injury | NCT03345576 |
| Study of Daily Application of Nestorone® (NES) and Testosterone (T) Combination Gel for Male Contraception | Clinical Evaluation of Daily Application of Nestorone® (NES) and Testosterone (T) Combination Gel for Male Contraception | NCT03452111 |
| Association Between the Prevalence of Cardiovascular Risk Factors and New Use of Testosterone | Association Between the Prevalence of Cardiovascular Risk Factors and New Use of Testosterone | NCT03484260 |
| Bipolar Androgen Therapy + Carboplatin in mCRPC | High Dose Testosterone + Carboplatin in Men With Advanced Prostate Cancer | NCT03522064 |
| Testosterone and Olaparib in Treating Patients With Castration-Resistant Prostate Cancer | Bipolar Androgen Therapy Plus Olaparib in Patient With Castration-Resistant Prostate Cancer | NCT03516812 |
| The effects of daily oral estrogen with or without low-dose transdermal testosterone gel in postmenopausal women with low sexual function | The effects of daily oral estrogen with or without low-dose transdermal testosterone gel in postmenopausal women with low sexual function | TCTR20180423001 |
| A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men | Testosterone Replacement Therapy for Assessment of Long-term Vascular Events and Efficacy ResponSE in Hypogonadal Men (TRAVERSE) Study | NCT03518034 |
| A study investigating whether testosterone and omega 3 from fish oil has an effect on the accumulation of protein plaques linked to Alzheimer’s disease in older men concerned about their memories | A 56 week, Double-Blind, Randomised Study to Evaluate the Efficacy of Testosterone, With and without DHA Supplementation on Cerebral Amyloid Load in Men with Subjective Memory Complaints | ACTRN12618000761268 |
| Testosterone in bariatric patients | Muscle strength and -mass after bariatric surgery - a possible effect of testosterone replacement therapy? Randomized, placebo-controlled and double-blinded study - Testosterone in bariatric patients | EUCTR2018-002365-19-DK |
| Testosterone Replacement Therapy and Liraglutide Effects on Weight Loss in Hypogonadism. | Effects of Liraglutide and Testosterone Replacement Therapy on Features of Hypogonadism and Weight Loss in Obese Men With Persistent Features of Hypogonadism. | NCT03619330 |
| Efficacy of Testosterone gel to restore normal serum values of testosterone during the acute phase of critical illness in adult ICU patients | Efficacy of Testosterone gel to restore normal serum values of testosterone during the acute phase of critical illness in adult ICU patients. An open-label parallel randomized controlled pilot study - TestICU-1 | EUCTR2017-004978-34-FR |
| A clinical study to assess efficacy and safety of daily administration of a nestorone/testosterone gel when administered in males | Clinical Evaluation of Daily Application of Nestorone® (NES) and Testosterone (T) Combination Gel for Male Contraception | EUCTR2016-002498-36-SE |
| Effect of Testosterone in COPD | Effect of Testosterone on Pulmonary Function in Male with Chronic Obstructive Pulmonary Disease | IRCT20180805040708N1 |
| Clinical trial of testosterone replacement therapy for the male hypogonadotropic hypogonadism with pituitary or hypothalamic tumor. | Clinical trial of testosterone replacement therapy for the male hypogonadotropic hypogonadism with pituitary or hypothalamic tumor. - T trial | JPRN-UMIN000033962 |
| Clinical Trial to Assess the Effect of Testosterone in Patients With Poor Ovarian Response (TESTOPRIM) | Clinical Effect of Follicular Preparation With Testosterone in Poor Ovarian Response: a Randomized Controlled Clinical Trial (TESTOPRIM) | NCT03378713 |
| Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression | A Randomized Phase II Study Comparing Sequential High Dose Testosterone and Enzalutamide to Enzalutamide Alone in Asymptomatic Men With Castration Resistant Metastatic Prostate Cancer | NCT04363164 |
| Prospective, open-label, multicenter clinical study on the efficacy and safety of recombinant human erythropoietin combined with retinoic acid and testosterone undecanoate in the treatment of anemia in patients with low-risk myelodysplastic syndrome | Prospective, open-label, multicenter clinical study on the efficacy and safety of recombinant human erythropoietin combined with retinoic acid and testosterone undecanoate in the treatment of anemia in patients with low-risk myelodysplastic syndrome | ChiCTR2000032845 |
| A Comparison of Side Effects in Hypogonadal Men Treated With Natesto Versus Testosterone Injections | A Comparison of Side Effects in Hypogonadal Men Treated With Natesto Versus Testosterone Injections: A Phase IV, Prospective, Randomized, Non-Blinded, Multi-Institutional Study | NCT04439799 |
| Perioperative Testosterone Replacement Therapy in Sarcopenic Male Colorectal Cancer Patients | Use of Perioperative Testosterone Replacement Therapy (TRT) in Sarcopenic Male Colorectal Cancer Patients - A Single Arm Open Label Feasibility Study | NCT05367284 |
| A study to find out clinical outcomes with variable durations of testosterone local application gel as pretreatment in patients with suspected poor results in IVF cycles | A Randomized Controlled Trial to assess the clinical outcomes with different durations of Transdermal Testosterone gel as pretreatment in patients with Poor prognosis in Antagonist IVF/ICSI cycles | CTRI/2022/03/040793 |
| Sexual Effects of Transdermal or Vaginal Testosterone | Effects of Vaginal or Transdermal Testosterone on Sexual Response and Climacteric Symptoms in Postmenopausal Women | NCT06794346 |
| T&T trial: adding Testosterone to Tamoxifen in male breast cancer patients | T&T trial: adding Testosterone to Tamoxifen in male breast cancer patients | EUCTR2021-002170-72-NL |
| The effect of Bisphosphonate on bone density in patients with major thalassemia | The effect of Bisphosphonate diet with and without testosterone on bone density parameters in male patients with major thalassemia | IRCT20201110049334N2 |
| TETRA-pilot: Testosterone in transgender women after vaginoplasty: a dose-finding and feasibility pilot study | TETRA-pilot: Testosterone in transgender women after vaginoplasty: a dose-finding and feasibility pilot study - TETRA-pilot | NL-OMON51335 |
| To compare the response of triple therapy (hCG, FSH and testosterone) and conventional therapy (hCG and FSH) in male Hypogonadotropic Hypogonadism | A randomized control trial comparing response of hCG, FSH and testosterone therapy and conventional treatment with hCG FSH in male hypogonadotropic hypogonadism | CTRI/2022/05/042795 |
| Testosterone injection in hypospadias surgery | The effect of testosterone injection on the results of hypospadias surgery | IRCT20200608047702N4 |
| Effect of Dose Fractionation of Testosterone Cypionate on Transgender Men with Erythrocytosis | Effect of Dose Fractionation of Testosterone Cypionate on Hematocrit in Transgender Men with Erythrocytosis Secondary to Testosterone Use. | NCT05487794 |
| BAseLine TEstosterone as a Prognostic and/or Predictive bioMARKer in mHSPC | Baseline Testosterone as a Prognostic and/or Predictive Biomarker in Metastatic Hormone Sensitive Prostate Cancer | NCT05530395 |
| Testosterone Undecanoate Replacement Therapy in Boys With Pubertal Delay or Confirmed Hypogonadism | Testosterone Undecanoate Replacement Therapy in Boys With Pubertal Delay or Confirmed Hypogonadism | NCT05541172 |
| Effect of dose fractionation of Testosterone on red blood cells in Transgender Men | Effect of dose fractionation of Testosterone Cypionete on hematocrit in Transgender Men with Erythrocytosis secondary to testosterone use | RBR-479v8tv |
| Subutanous testosterone therapy in hypogonadal men | Study of efficacy and patient satisfaction with subcutaneous vs intramuscular testosterone enanthate in hypogonadal male patients | CTRI/2023/01/049024 |
| Testosterone based dosing regimen of goserelin in patients with prostate cancer | Testosterone based dosing regimen of goserelin in patients with prostate cancer - TEST-TOSTERON | NL-OMON54398 |
| Evaluating Testosterone Therapy to Prevent Heart Failure in Women: The ETHEL study. | Evaluating Testosterone Therapy to Prevent Heart Failure in Women: The ETHEL study. | ACTRN12623000165684 |
| : Evaluation of the early effect of drugs in patients with neurological damage | : Evaluation of the early effect of erythropoietin and testosterone in patients with neurological damage | IRCT20170105031787N5 |
| The use of testosterone in brain dead patients who are candidates for organ donation in order to maintain and stabilize blood pressure | The effects of testosterone injection in maintaining the stability of blood pressure and hemodynamic parameters of brain dead patients who are candidates for organ donation | IRCT20130304012695N17 |
| EFFECT OF TESTOSTERONE HORMONAL THERAPY IN GENERAL WELL-BEING OF TRANSMALE (FEMALE TO MALE)INDIVIDUALS | GENDER AFFIRMING CROSS-SEX HORMONAL THERAPY IN TRANSMALES- A COMPARATIVE STUDY USING TWO DIFFERENT TESTOSTERONE FORMULATIONS | CTRI/2023/05/052920 |
| Klinefelter syndrome – the effect of Testosterone treatment In PubertYA randomized, double-blind placebo-controlled intervention study ‘The TiPY study’ | Klinefelter syndrome – the effect of Testosterone treatment In PubertYA randomized, double-blind placebo-controlled intervention study ‘The TiPY study’ | CTIS2023-505854-16-00 |
| Does Human Skeletal Muscle Possess an Epigenetic Memory of Testosterone? | Does Human Skeletal Muscle Possess an Epigenetic Memory of Testosterone? | NCT05964920 |
| Effect of testosterone replacement associated with bariatric surgery in men with obesity | Effect of testosterone replacement associated with bariatric surgery in men with obesity: a randomized trial | RBR-9qks3pc |
| Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer | Repeat Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Asymptomatic Patients With Metastatic Castration-Resistant Prostate Cancer: The APEX (Androgen and Polyamine Elimination Alternating With Xtandi) Trial | NCT06059118 |
| Evaluation of the Activity of Supraphysiological Testosterone Doses in the Fall of PSA in Patients with Prostate Cancer Unresponsive to the lack of Testosterone and without Metastases | Evaluation of supraphysiological doses of Testosterone in patients with castration-resistant prostate Adenocarcinoma without metastases | RBR-8m3htgm |
| An Open-Label Study of 50 Mg Oral Testosterone Undecanoate (Kyztrex) in Menopausal Women with Low Testosterone and HSDD | An Open-Label Pilot Study of the Pharmacokinetics and Safety of 50 Mg Oral Testosterone Undecanoate (Kyzatrex) in Menopausal Women with Low Testosterone and Hypoactive Sexual Desire Disorder | NCT06082817 |
| Transdermal Testosterone for Poor Responder Patients Undergoing Controlled Ovarian Stimulation Prior to IVF | Transdermal Testosterone for Poor Responders Undergoing IVF | NCT03078569 |
| Impact of Testosterone on Epigenetic regulated of Cellular senescence in Transgender men | Impact of Testosterone on Epigenetic regulated of Cellular senescence in Transgender men | TCTR20231014006 |
| Role of Anabolic Steroids on Intensive Care Unit-Acquired Weakness | Pilot Randomized, Controlled Trial of Testosterone Therapy in Chronic Critically Ill Patients and Its Potential Effects on Weaning From Mechanical Ventilation and Intensive Care Unit-acquired Weakness | NCT03038919 |
| Clinical trial to assess de effect of testosterone in patients with poor ovarian response. | Clinical effect of follicular preparation with testosterone in poor ovarian response: a randomized controlled clinical trial (TESTOPRIM) | EUCTR2016-004302-33-ES |
| The effect of sublingual minoxidil in trans people with androgenic alopecia receiving testosterone for gender-affirmation | The effect of low-dose sublingual minoxidil in transgender and gender-diverse individuals assigned female at birth with androgenic alopecia while on testosterone for gender-affirmation | ACTRN12623000356662 |
| Impact of topical testosterone on lipid profile in women with decreased sexual desire: A randomized controlled double-blind study. | The impact of transdermal Testosterone Nanoemulsion on lipid profile in women with Hypoactive Sexual Desire: A double-blind randomized controlled study | RBR-8kmydzj |
| Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate Cancer | A Phase II Study Assessing the Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate Cancer | NCT05081193 |
| Comparison of the Concentration of Estrogen and Testosterone Ratio in Male Patients With Cirrhosis and Hypotension | Comparison of the Concentration of Estrogen and Testosterone Ratio in Male Patients With Cirrhosis and Hypotension Compared to Male Cirrhosis Patients Without Hypotension | NCT05051293 |
| Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury | Locomotor Training With Testosterone to Promote Bone and Muscle Health | NCT04460872 |
| Effects of Testosterone Plus Dutasteride or Placebo on Muscle Strength, Body Composition and Metabolism in Transmen | A Randomized Double-blind Placebo-controlled Pilot Trial on the Effects of Testosterone Undecanoate Plus Dutasteride or Placebo on Muscle Strength, Body Composition and Metabolic Profile in Transmen | NCT04545450 |
| Efficacy and Safety of Low-dose Ruxoltinib Combined with Thalidomide, Prednisone, and Testosterone Decanoate (TPT) in Patients with Lower and Intermediate Risk Myelofibrosis ---a Single Arm, Multicenter, and Prospective Study | Efficacy and Safety of Low-dose Ruxoltinib Combined with Thalidomide, Prednisone, and Testosterone Decanoate (TPT) in Patients with Lower and Intermediate Risk Myelofibrosis ---a Single Arm, Multicenter, and Prospective Study | ChiCTR2000035444 |
| Effects of Testosterone on Myocardial Repolarization | Effects of Testosterone on Myocardial Repolarization in Patients With Hypogonadism With/Without Chronic Heat Failure (NYHA Class I-II) | NCT03126656 |
| Effects of Mucuna Pruriens Supplementation on muscle gain, strenth and testosterone concentration in resistance trained men | Effects of Mucuna Pruriens Supplementation on muscular hypertrophy, strength and free testosterone concentrarion in resistance trained men | RBR-8fb7q2 |
| Extreme Bipolar Androgen Therapy With Darolutamide and Testosterone Cypionate in Patients With Metastatic Castration-Resistant Prostate Cancer (ExBAT Trial) | Extreme Bipolar Androgen Therapy With Darolutamide and Testosterone Cypionate in Patients With Metastatic Castration-Resistant Prostate Cancer (ExBAT Trial) | NCT04558866 |
| Effect of Testosterone Pretreatment in POR | Therapeutic Effect of Prolonged Testosterone Pretreatment in Women With Poor Ovarian Response: a Randomized Control Trial | NCT04602143 |
| Testosterone gel in Depression | Comparing the effect of two dosing regimen of testosterone gel 1%(once daily versus two divided doses) on refractory depression(MDD) in depressed men | IRCT20191211045698N1 |
| Clinical Role of Testosterone and Dihydrotestosterone and Which of Them Should be Inhibited in COVID-19 Patients - A Double-edged Sword? | Clinical Role of Testosterone and Dihydrotestosterone and Which of Them Should be Inhibited in COVID-19 Patients - A Double-edged Sword? | NCT04623385 |
| Additional Testosterone treatment in heart failure. | Adjuvant testosterone therapy in chronic heart failure - A Randomized Open Label Clinical Trial | CTRI/2021/01/030292 |
| The Effects of Testosterone Supplementation in Aging Men with Heart Failure | A Study of Quality of Life, Frailty Status and Functional Capacity among Elderly Males with Chronic Stable Heart Failure after Transdermal Testosterone Therapy: A Prospective Cohort Study | CTRI/2021/01/030307 |
| Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low Testosterone | Perioperative Testosterone Replacement Therapy Improves Outcomes: A Pilot Safety and Feasibility Study | NCT04731376 |
| THE PREVALENCE AND ASSOCIATED FACTORS OF TESTOSTERONE DEFICIENCY IN THAI MEN WITH TYPE 2 DIABETES MELLITUS IN KING CHULALONGKORN MEMORIAL HOSPITAL | THE PREVALENCE AND ASSOCIATED FACTORS OF TESTOSTERONE DEFICIENCY IN THAI MEN WITH TYPE 2 DIABETES MELLITUS IN KING CHULALONGKORN MEMORIAL HOSPITAL | TCTR20210127001 |
| Impact of peri-operative tEstosterone levels on oNcological and Functional Outcomes in RadiCal prostatEctomy (ENFORCE trial) | Impact of peri-operative tEstosterone levels on oNcological and Functional Outcomes in RadiCal prostatEctomy (ENFORCE trial) | NL-OMON25840 |
| Characteristics of the Vaginal Microbiome Before and After Testosterone Treatment in Transgender Men | Characteristics of the Vaginal Microbiome Before and After Testosterone Treatment in Transgender Men | TCTR20210202007 |
| Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism | Androgen Replacement to Improve Patient-Important Outcomes in Men With Opioid-Induced Hypogonadism | NCT04798469 |
| Testosterone and Neurovascular Control in Humans | Exploring the Role of Testosterone on Neurovascular Control in Humans | NCT04819204 |
| Testosterone Treatment in a Patient With 17ß-hydroxysteroid Dehydrogenase Type 3 Deficiency: an N-of-1 Study | Testosterone Treatment in a Patient With 17ß-hydroxysteroid Dehydrogenase Type 3 Deficiency: an N-of-1 Study | NCT04831099 |
| Administration study on preparation of testosterone undecanoate to healthy adult males | Administration study on preparation of testosterone undecanoate to healthy adult males | JPRN-jRCT1071210006 |
| Study of Testosterone and rHGH in FSHD | Study of Testosterone and rHGH in FSHD (STARFISH): A Proof-of-Concept Study | NCT03123913 |
| A multicenter, open label, variable dose, two arm pilot paediatric phase 1 PK study to evaluate testosterone nasal gel (4.5% w/w) in hypogonadal boys | A multicenter, open label, variable dose, two arm pilot paediatric phase 1 PK study to evaluate testosterone nasal gel (4.5% w/w) in hypogonadal boys | EUCTR2017-001012-11-GB |
| Pharmacokinetics of Subcutaneous Injection (SC)of Testosterone in an Oil Vehicle: Nandrolone (ND) in Healthy Volunteers | Pharmacokinetics of Subcutaneous Injection (SC)of Testosterone in an Oil Vehicle: Nandrolone (ND) in Healthy Volunteers | ACTRN12613000068763 |
| Subcutaneous vs. Intramuscular Testosterone | Subcutaneous Testosterone Therapy in Men Compared to Intramuscular Testosterone Therapy in Men | NCT03091348 |
| Non-interventional, prospective health services research study on the course of testosterone levels during androgen deprivation therapy (ADT) with LHRH analogues (3-month depot). | "Non-interventional, prospective health services research study on the course of testosterone levels during androgen deprivation therapy (ADT) with LHRH analogues (3-month depot). - ""TestoVer""-Study" | DRKS00009995 |
| Testosterone Replacement to Alleviate Pain in Postmenopausal Women (TRAPP Trial) | Exploring the Role of Testosterone as a Novel Anti-Nociceptive Agent in Women With Chronic Pain and Opioid Use | NCT04895306 |
| Effects of early testosterone gel administration on physical performance in the critically ill | Effects of early testosterone gel administration on physical performance in the critically ill: a randomised double blind clinical trial - TestICUs | EUCTR2019-004599-20-FR |
| Testosterone for gender dysphoria in transgender men | A randomised controlled trial of testosterone treatment on gender dysphoria, depression, suicidality and quality of life in transgender men | ACTRN12621000716864 |
| High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers | High-dose Testosterone in Men With Metastatic Castration-resistant Prostate Cancer and ATM or CDK12 Deficiency | NCT05011383 |
| Investigating the effect of topical testosterone cream on bone loss and sexual function in women with premature ovarian insufficiency and early menopause: a randomized, double blind, placebo-controlled trial.. | Investigating the effect of topical testosterone cream on bone loss and sexual function in women with premature ovarian insufficiency (POI) and early menopause (EM): a randomized, double blind, placebo-controlled trial. | ACTRN12621001100886 |
| Testosterone and Neural Function | The Role of Androgens in Neurophysiological and Autonomic Function in Male Veterans With Spinal Cord Injury | NCT06130449 |
| Hormone treatment of boys with absent or delayed puberty | A multicenter and randomised clinical study on pubertal replacement therapy in boys - Treatment of boys with absent or delayed puberty with rhFSH and two different formulations of testosterone in low dose: Testoviron Depot® and Nebido® - Pubertal replacement therapy in boys | EUCTR2012-002337-11-SE |
| EFFECT OF TESTOSTERON THERAPY ON LOW URINARY TRACT | EVALUATION OF THE EFFECT OF TESTOSTERONE REPLACEMENT THERAPY ON PROSTATIC INFLAMMATION AND LOWER URINARY TRACT SYMPTOMS IN HYPOGONADAL SUBJECTS - Florence-PROTEST | EUCTR2012-003494-26-IT |
| A randomized, cross-over controlled study to compare the pharmacokinetic profiles of sublingual administered testosterone solution followed by a buspirone tablet, versus sublingual testosterone and buspirone combined in one tablet in healthy premenopausal women | A randomized, cross-over controlled study to compare the pharmacokinetic profiles of sublingual administered testosterone solution followed by a buspirone tablet, versus sublingual testosterone and buspirone combined in one tablet in healthy premenopausal women - PK-Lybridos Formulation 1 and 2 | NL-OMON37493 |
| 28-Day Study of Testosterone Co-administered With Dutasteride in Hypogonadal Men | A Phase II, 28-Day, Randomized, Parallel-Group, Open-Label Study Evaluating the Efficacy and Safety of Twice Daily Oral Doses of Testosterone (150-400mg) Co-administered With 0.25mg Dutasteride Compared With 400mg Testosterone Alone and 0.25mg Dutasteride Alone in the Treatment of Hypogonadism | NCT00398580 |
| Analgesic Efficacy of Testosterone Replacement in Hypogonadal Opioid-treated Chronic Pain Patients: A Pilot Study. | Analgesic Efficacy of Testosterone Replacement in Hypogonadal Opioid-treated Chronic Pain Patients: A Pilot Study. | NCT00398034 |
| Testosterone Therapy in Naturally Menopausal Women With Low Sexual Desire Receiving Transdermal Estrogen | 24-Week Study to Evaluate the Efficacy/Safety of Transdermal Testosterone in Naturally Menopausal Women With Hypoactive Sexual Desire Disorder Receiving Systemic Transdermal Estrogen Therapy. | NCT00384046 |
| Neural correlates of sexual arousal during treatment of testosterone combined with sildenafil in healthy female subjects with FSD. Effects of differing levels of attentional engagement on neural correlates of sexual arousal induced by an erotic film | Neural correlates of sexual arousal during treatment of testosterone combined with sildenafil in healthy female subjects with FSD. Effects of differing levels of attentional engagement on neural correlates of sexual arousal induced by an erotic film | EUCTR2006-005139-61-NL |
| Testosterone Effects on Men With the Metabolic Syndrome | Effect of Increasing Testosterone Levels on Insulin Sensitivity in Men With the Metabolic Syndrome | NCT00382057 |
| A randomised placebo-controlled trial of testosterone undecanoate in obese men as adjuvant therapy for a weight loss program | A randomised placebo-controlled trial of testosterone undecanoate in obese men as adjuvant therapy for a weight loss program | ACTRN12606000404527 |
| Testosterone therapy as an adjunct to exercise rehabilitation: effects on exercise capacity, inflammatory markers and quality of life in hypogonadal males with chronic heart failure | | ISRCTN99667121 |
| Pharmacokinetics of Testosterone Lotion in the Treatment of Hypogonadal Males | A Phase II Randomised, Two-Way Crossover Study to Compare the Steady State Pharmacokinetics of Testosterone Following Application of Different Testosterone Metered-Dose (MD) Lotion Doses in Hypogonadal Male Subjects | NCT00372008 |
| Effects of Testosterone Gel on Carbohydrate and Lipid Metabolism In Elderly Obese Men | Investigator Initiated Study of the Effects of Androgen Therapy on Carbohydrate and Lipid Metabolism In Elderly Men | NCT00365794 |
| Testosterone Replacement in Diabetes With Vascular Disease (Version 2) | A Randomised, Double Blind, Placebo-controlled Parallel Study to Test the Effect of Testosterone Treatment on Peripheral Vascular Disease in Hypogonadal Men With Type 2 Diabetes Mellitus | NCT00355537 |
| The Quality of Life Outcomes and the Pharmacokinetic and Pharmacodynamic Sequelae of Testosterone Undecanoate Injections compared with Testosterone Implants for Androgen Replacement Therapy in men with Classical Male Hypogonadism | The Quality of Life Outcomes and the Pharmacokinetic and Pharmacodynamic Sequelae of Testosterone Undecanoate Injections compared with Testosterone Implants for Androgen Replacement Therapy in men with Classical Male Hypogonadism | ACTRN12606000315516 |
| Study to Assess the Efficacy/Safety of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido | A Study to Evaluate the Efficacy/Safety of Transdermal Testosterone for 24 Weeks in Naturally Menopausal Women With Hypoactive Sexual Desire Disorder on Oral Hormone Replacement Therapy. | NCT00349791 |
| Testosterone for Men With Insulin Treated Type 2 Diabetes | A Randomised Double Blind Placebo Controlled, Parallel Pilot Study to Test the Effect of Testosterone Replacement on Glycaemic Control and Arterial Wall Properties of Hypogonadal Men With Type 2 Diabetes Treated With Insulin | NCT00349362 |
| A randomised placebo controlled study of transdermal testosterone therapy (testosterone 1% hydroalcohol gel) to investigate the efficacy and safety in men with abdominal obesity, low testosterone levels and early stages of the metabolic cluster syndrome. - ARTinMMS | A randomised placebo controlled study of transdermal testosterone therapy (testosterone 1% hydroalcohol gel) to investigate the efficacy and safety in men with abdominal obesity, low testosterone levels and early stages of the metabolic cluster syndrome. - ARTinMMS | EUCTR2006-003101-53-SE |
| Exercise and Testosterone Therapy in Elderly Men With Physical Frailty | Exercise and Testosterone Therapy in Elderly Men With Physical Frailty | NCT00345969 |
| A Randomised, Double-Blind, Placebo-Controlled, Parallel-group, Multicentre, 24 week Study to Evaluate the Efficacy and Safety of Transdermal Testosterone (300 mcg/day) in Naturally Menopausal Women with Hypoactive Sexual Desire Disorder Receiving Systemic Transdermal Estrogen, Oral Non-Conjugated Equine Estrogen, or No Estrogen Therapy - ADORE | A Randomised, Double-Blind, Placebo-Controlled, Parallel-group, Multicentre, 24 week Study to Evaluate the Efficacy and Safety of Transdermal Testosterone (300 mcg/day) in Naturally Menopausal Women with Hypoactive Sexual Desire Disorder Receiving Systemic Transdermal Estrogen, Oral Non-Conjugated Equine Estrogen, or No Estrogen Therapy - ADORE | EUCTR2006-001179-39-GB |
| Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido | Study to Evaluate Efficacy and Safety of Transdermal Testosterone and Safety for an Open-label Period in Women With Hypoactive Sexual Desire Disorder on Estrogen Replacement Therapy and Undergone Hysterectomy/Bilateral Oophorectomy. | NCT00331123 |
| Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido | Study to Evaluate the Efficacy and Safety of Transdermal Testosterone in Women With Hypoactive Sexual Desire Disorder on Concurrent Estrogen Replacement Therapy and Undergone Hysterectomy/Bilateral Oophorectomy | NCT00331214 |
| Testosterone therapy as an adjunct to exercise rehabilitation: effects on exercise capacity, inflammatory markers and quality of life in hypogonadal males with chronic heart failure. - none | Testosterone therapy as an adjunct to exercise rehabilitation: effects on exercise capacity, inflammatory markers and quality of life in hypogonadal males with chronic heart failure. - none | EUCTR2006-001090-23-GB |
| Phase IIIB, Double Blind, Placebo Controlled, International, Multicenter, Parallel Group Study, to Assess the Efficacy and Safety of Testim Gel in Combination with a Phosphodiesterase V Inhibitor (Tadalafil), in Male Patients with Low or Baseline Serum Testosterone Levels and Erectile Dysfunction - TESTIMED | Phase IIIB, Double Blind, Placebo Controlled, International, Multicenter, Parallel Group Study, to Assess the Efficacy and Safety of Testim Gel in Combination with a Phosphodiesterase V Inhibitor (Tadalafil), in Male Patients with Low or Baseline Serum Testosterone Levels and Erectile Dysfunction - TESTIMED | EUCTR2005-005060-92-GB |
| Testosterone-Driven Growth-Hormone (GH) Secretion in Aging Men | Mechanisms of Testosterone-Driven Growth-Hormone (GH) Secretion in Aging Men: Modulation of GHRH, GHRP and Somatostatin Action by Estrogenic Versus Androgenic Steroids | NCT00309855 |
| Does Testosterone Improve Function in Hypogonadal Older Men | Does Testosterone Improve Function in Hypogonadal Older Men | NCT00304213 |
| Effect of transdermal testosterone replacement in hypogonadal men with decreased insulin sensitivity | | ISRCTN45741714 |
| Testosterone Replacement in Older Men and Atherosclerosis Progression | Effects of Testosterone Replacement on Atherosclerosis Progression in Older Men With Low Testosterone Levels | NCT00287586 |
| Testosterone Therapy After Hip Fracture in Elderly Women | Testosterone Therapy After Hip Fracture in Elderly Women | NCT00280267 |
| Testosterone Replacement Therapy in Chronic Spinal Cord Injury | Testosterone Replacement Therapy in Chronic Spinal Cord Injury | NCT00266864 |
| Testosterone and Physical Function in HIV+ Men | Testosterone and Physical Function in HIV Associate Weight Loss | NCT00260143 |
| A Study to Test a Measure of Symptoms of Older Men With Low Testosterone On and Off Testosterone Replacement Treatment (P05815) | A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Two Period Cross Over Trial to Validate Patient-Reported Outcome Measures for Use in Men With Late Onset Hypogonadism | NCT00254553 |
| Study of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido | A Study to Evaluate the Efficacy/Safety of Transdermal Testosterone for 52 Weeks and Safety for 52 Weeks in Naturally Menopausal Women With Hypoactive Sexual Desire Disorder on Oral Hormone Replacement Therapy. | NCT00338312 |
| CROSS-OVER COMPARISON OF TESTOSTERONE SERUM LEVELS IN HYPOGONADAL MEN TREATED WITH L0074 TESTOSTERONE PATCH 60CM2 (2 patches/48H) AND ORAL TESTOSTERONE UNDECANOATE -PANTESTONE® 40mg- (2 caps, bid) - NA | CROSS-OVER COMPARISON OF TESTOSTERONE SERUM LEVELS IN HYPOGONADAL MEN TREATED WITH L0074 TESTOSTERONE PATCH 60CM2 (2 patches/48H) AND ORAL TESTOSTERONE UNDECANOATE -PANTESTONE® 40mg- (2 caps, bid) - NA | EUCTR2004-004891-36-ES |
| Oral Androgens in Man-4: (Short Title: Oral T-4) | Oral Androgens in Man-4: Gonadotropin Suppression Medicated by Oral Testosterone Enanthate in Oil Plus Dutasteride (Short Title: Oral T-4) | NCT00399165 |
| Hormonal Contraception in Healthy Young Men (P42306)(COMPLETED)(P06057) | A Phase II -b, Placebo-Controlled Trial Investigating the Efficacy, Safety and Pharmacokinetics of a Subcutaneous Etonogestrel Implant Combined With i.m. Testosterone Undecanoate for Male Contraception | NCT00403793 |
| The efficacy and safety of 2.5% testosterone gel for late-onset hypogonadsism patients evaluated by using salivary testosterone. | The efficacy and safety of 2.5% testosterone gel for late-onset hypogonadsism patients evaluated by using salivary testosterone. - The efficacy of 2.5% testosterone gel for late-onset hypogonadsism patients | JPRN-UMIN000001011 |
| Testosterone and Lipolysis, Insulin Sensitivity and Protein Metabolism | Testosterone and Lipolysis, Insulin Sensitivity and Protein Metabolism | NCT00613288 |
| Testosterone and Weight Loss | Effect of Testosterone and Diet on Weight | NCT01616732 |
| Treatment of Erectile Dysfunction in Hypogonadal Men With Testosterone Undecanoate | Treatment of Erectile Dysfunction in Hypogonadal Men With Testosterone Undecanoate i.m. 1000 mg. A Prospective, Multi-Center Clinical Study Phase IV. | NCT00555087 |
| Hormone and Information Processing Study | Testosterone Supplementation in Men With MCI | NCT00539305 |
| A Study of Fortigel Testosterone Gel 2% in Males With Low Testosterone | An Open Label Phase 3 Study of Fortigel Testosterone Gel 2% in Hypogonadal Males | NCT00522431 |
| A methodological investigation to test acute changes in female sexual desire in healthy volunteersand pre- and postmenopausal women diagnosed with hypoactive sexual desiredisordersusing explicit measures in a controlled laboratory setting and behavioral measures at home, in no-drug as well as placebo-controlled within subjects cross-over drug (a single dose of testosterone gel 50mg [1% in 5g] conditions. - PDS study | A methodological investigation to test acute changes in female sexual desire in healthy volunteersand pre- and postmenopausal women diagnosed with hypoactive sexual desiredisordersusing explicit measures in a controlled laboratory setting and behavioral measures at home, in no-drug as well as placebo-controlled within subjects cross-over drug (a single dose of testosterone gel 50mg [1% in 5g] conditions. - PDS study | EUCTR2007-003343-74-NL |
| Effect of Testosterone in Men With Erectile Dysfunction | Androgen Modulation of Response to Selective Phosphodiesterase Inhibitors in Erectile Dysfunction | NCT00512707 |
| Testosterone Improves Exercise Oxygen Uptake, Insulin Resistance and Muscle Strength in Elderly Patients With Chronic Heart Failure | Long-Acting Testosterone Improves Exercise Oxygen Uptake, Insulin Resistance and Muscle Strength in Elderly Patients With Chronic Heart Failure | NCT00512408 |
| Testosterone for Peripheral Vascular Disease | A Randomised, Double Blind, Placebo Controlled, Parallel Pilot Study to Test the Effect of Testosterone Treatment on Peripheral Vascular Disease in Hypogonadal Men With Type 2 Diabetes Mellitus | NCT00504712 |
| Androgen Therapy for Breast Cancer Patients With Aromatase Inhibitor Induced Side-Effects | Phase II Study of Testosterone Replacement in Women Experiencing Aromatase Inhibitor Side-Effects in Adjuvant Therapy for Breast Cancer | NCT00497458 |
| The Role of 5-alpha Reductase in Mediating Testosterone Actions | The Role of 5-alpha Reductase in Mediating Testosterone Actions | NCT00493987 |
| TDSM- Testosterone Dose Response in Surgically Menopausal Women | Testosterone Dose Response in Surgically Menopausal Women | NCT00494208 |
| Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without Dutasteride | An Open Label Study to Evaluate the Impact of Novel Fixed-dose Testosterone/Dutasteride Combinations on the Relative Bioavailability of the Individual Dutasteride and Testosterone Components | NCT00400335 |
| Effect of Testosterone Replacement on Insulin Resistance | Effect of Testosterone Replacement on Insulin Resistance in Hypogonadal, Non-obese Men With Metabolic Syndrome | NCT00487734 |
| Phase II multi-centre, randomised, open, comparative study of the safety and efficacyof transdermal testosterone (Testim®) compared to intramuscular testosteronedepot for the induction of puberty in boys with hypogonadism and delayed puberty - Testim® in delayed puberty | Phase II multi-centre, randomised, open, comparative study of the safety and efficacyof transdermal testosterone (Testim®) compared to intramuscular testosteronedepot for the induction of puberty in boys with hypogonadism and delayed puberty - Testim® in delayed puberty | EUCTR2006-005200-13-DE |
| Long-term Safety Study of Intramuscular Injections of 750 mg and 1000 mg Testosterone Undecanoate in Hypogonadal Men | A Two-Arm, Open-Label, Randomized, Multi-Center Pharmacokinetic and Long-Term Safety Study of Intramuscular Injections of 750 mg and 1000 mg Testosterone Undecanoate in Hypogonadal Men | NCT00467870 |
| Endometrial Safety Study of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal Women | A Randomized, Double-Blind, Placebo-controlled, Multicenter, 52-week Study to Evaluate the Endometrial Safety of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal Women With Hypoactive Sexual Desire Disorder. | NCT00467259 |
| 5-Alpha Reductase and Anabolic Effects of Testosterone | 5-Alpha Reductase and Anabolic Effects of Testosterone | NCT00475501 |
| Safety of Testosterone Undecanoate i.m. in Hypogonadal Men | Long-Term Intervention Phase 2 Study of Safety Aspects of Testosterone Undecanoate i.m. in Hypogonadal Men | NCT00452322 |
| Effect of Testosterone Gel Replacement on Fat Mass in Males With Low Testosterone Levels and Diabetes | Effect of Androgel on Total and Regional Adipose Tissue and Lean Body Mass in Type 2 Diabetic Patients With Hypogonadism | NCT00440440 |
| Effect of Increasing Testosterone on Insulin Sensitivity in Men With the Metabolic Syndrome | Effect of Increasing Testosterone on Insulin Sensitivity in Men With the Metabolic Syndrome | NCT00438321 |
| Role of testosterone and its metabolites on different physiological functions in subjects affected by gender identity disorde GID FtM transsexuals | Role of testosterone and its metabolites on different physiological functions in subjects affected by gender identity disorde GID FtM transsexuals | EUCTR2006-004872-11-IT |
| Testosterone Treatment for Hypogonadal Men | A Multi-Center, Randomized, Double-Blind,Placebo-Controlled Efficacy and Safety Study of Testosterone Gel 1.62% for the Treatment of Hypogonadal Men | NCT00433199 |
| Neural correlates of sexual arousal during treatment of testosterone combined with sildenafil in healthy female subjects with FSD. Effects of differing levels of attentional engagement on neural correlates of sexual arousal induced by an erotic film. | Neural correlates of sexual arousal during treatment of testosterone combined with sildenafil in healthy female subjects with FSD. Effects of differing levels of attentional engagement on neural correlates of sexual arousal induced by an erotic film. | EUCTR2007-000257-56-NL |
| Transdermal Testosterone Gel/Effect on Erection Quality as Measured by DIR | Phase I Study of Transdermal Testosterone Gel and Its Effect on Erection Quality as Measured by a Digital Inflection Rigidometer (DIR) | NCT00425568 |
| The Therapy of Nebido as Mono or in Combination With PDE-5 Inhibitors in Hypogonadal Patients With Erectile Dysfunction | Phase IV Study of The Therapy of Long-acting Testosterone Undecanoate,1000mg in 4 ml Oily Solution for i.m.Injection(Nebido) as Mono or in Combination With PDE-5 Inhibitors in Hypogonadal Patients With Erectile Dysfunction | NCT00421460 |
| Testosterone Treatment for Multiple Sclerosis | Testosterone Treatment for Multiple Sclerosis: A Preliminary Trial | NCT00405353 |
| Testosterone Therapy in Men With Low Testosterone Levels and Metabolic Syndrome or Early Stages of Type 2 Diabetes | A Randomised Placebo Controlled Study of Transdermal Testosterone Therapy to Investigate the Efficacy and Safety in Men With Abdominal Obesity, Low Testosterone Levels and Early Stages of the Metabolic Cluster Syndrome. | NCT00479609 |
| Testosterone Gel in Preventing Weakness Caused by Steroid Therapy in Men With Glioma | A Randomized, Controlled Comparative Trial to Determine if Testosterone Gel Prevents Steroid Related Weakness in Brain Cancer Patients | NCT00631137 |
| Co-Administering Testosterone With PDE5 Inhibitors in ED Patients Non Responders to PDE5 Inhibitors Alone | Double-Blind, Placebo Controlled Randomized Study of Co-Administering Testosterone With PDE5 Inhibitors in Patients Non-Responders to PDE5 Inhibitors Alone | NCT00244023 |
| Testosterone and Myocardial Perfusion in Coronary Heart Disease (CHD) | Effects of Chronic Testosterone on Myocardial Ischaemia and Endothelial Function in Men With Documented Coronary Heart Disease | NCT00239590 |
| The Effects of Testosterone and Nutritional Supplementation in the Undernourished Elderly | The Effects of Testosterone and Nutritional Supplementation, Alone and Combined, on the Adverse Effects of Under-Nutrition in the Elderly | NCT00117000 |
| The Effects of Long term testosterone supplementation In testosterone deficient men on Quality of life, Sarcopenia, cognitive function, Obesity and vasculaR ageing | The effects of testosterone supplementation on functional mobility, quality of life, body composition, cognitive function, aortic stiffness and cardiovascular risk factors, and bone mineral density in ageing men with an age-related decline of testosterone | ISRCTN23688581 |
| The effect of testosterone therapy on angina threshold and atheroma in patients with stable angina - n/a | The effect of testosterone therapy on angina threshold and atheroma in patients with stable angina - n/a | EUCTR2005-000027-42-GB |
| The effects of testosterone therapy in men with pulmonary hypertension | The effects of testosterone therapy in men with pulmonary hypertension | EUCTR2004-003844-24-GB |
| The acute effects of testosterone administration in patients with pulmonary hypertension | The acute effects of testosterone administration in patients with pulmonary hypertension | EUCTR2004-003843-28-GB |
| The effects of testosterone therapy in men with pulmonary hypertension | The effects of testosterone therapy in men with pulmonary hypertension | EUCTR2005-000049-12-GB |
| The Effects of testosterone supplementation on functional mobility, quality of life, body composition, cognitive function, aortic stiffness and cardiovascular risk factors, and bone mineral density in ageing men with an age-related decline of testosterone. | The Effects of testosterone supplementation on functional mobility, quality of life, body composition, cognitive function, aortic stiffness and cardiovascular risk factors, and bone mineral density in ageing men with an age-related decline of testosterone. | NL-OMON21427 |
| A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter, 52-week Study to Evaluate the Efficacy ans Safety of Transdermal Patches Delivering 150 or 300 microgram/day Testosterone in Menopausal Women with Low Libido Not Receiving Systemic Estrogen or Estrogen Progestin Therapy - Aphrodite | A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter, 52-week Study to Evaluate the Efficacy ans Safety of Transdermal Patches Delivering 150 or 300 microgram/day Testosterone in Menopausal Women with Low Libido Not Receiving Systemic Estrogen or Estrogen Progestin Therapy - Aphrodite | EUCTR2004-001222-25-SE |
| Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease | Biomarkers, Breast Density And Risk Reduction Perspectives In BRCA Carriers | NCT00080756 |
| Testosterone and Growth Hormone for Bone Loss in Men | Will Testosterone and Growth Hormone Improve Bone Structure? | NCT00080483 |
| Sperm suppression and contraceptive protection provided by norethisterone enantate (NET-EN) combined with testosterone undecanoate (TU) in healthy men | Sperm suppression and contraceptive protection provided by norethisterone enantate (NET-EN) combined with testosterone undecanoate (TU) in healthy men | ISRCTN07760234 |
| Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors | The Use of Low Dose Testosterone To Enhance Libido In Female Cancer Survivors: A Phase III Randomized, Placebo-Controlled, Double-Blind Crossover Study | NCT00075855 |
| The Effect of 5-Alpha Reductase on Testosterone in Men | The Role of 5-Alpha Reductase in Mediating Testosterone Actions | NCT00070733 |
| Older Men and Testosterone | | NCT00119483 |
| Administration of testosterone to women with androgen insensitivity: a study of the role of androgen replacement on psychological function | Administration of testosterone to women with androgen insensitivity: a study of the role of androgen replacement on psychological function | ISRCTN17551969 |
| Physiologic Effects of PRMS & Testosterone in the Debilitated Elderly | Physiologic Effects of PRMS & Testosterone in the Debilitated Elderly | NCT00018356 |
| Testosterone for HIV-Positive Men With Reduced Serum Testosterone Levels and Abdominal Fat | A Prospective, Multicenter, Randomized, Placebo-Controlled Trial of Physiologic Testosterone Supplementation for HIV-Positive Men With Mildly to Moderately Reduced Serum Testosterone Levels and Abdominal Obesity | NCT00009555 |
| AIDS Wasting in Women: Anabolic Effects of Testosterone | | NCT00006158 |
| Randomized Study of Testosterone and Progressive Resistance Exercise in Men With Burn Injury | | NCT00006129 |
| Testosterone in Treating Patients With Progressive Prostate Cancer That No Longer Responds to Hormone Therapy | A Phase I Trial of Testosterone in Patients With Progressive Androgen-Independent Prostate Cancer | NCT00006044 |
| Phase II Study of Leuprolide and Testosterone for Men With Kennedy's Disease or Other Motor Neuron Disease | | NCT00004771 |
| A Study of Megestrol Acetate Alone or in Combination With Testosterone Enanthate Drug in the Treatment of HIV-Associated Weight Loss | Double-Blind Randomized Comparison Phase II Trial of Megestrol Acetate and Testosterone Enanthate in Combination Versus Megestrol Acetate Plus Testosterone Enanthate Placebo in Human Immunodeficiency Virus (HIV)-Associated Wasting. | NCT00001079 |
| Phase II Randomized Study of Physiologic Testosterone Replacement in Premenopausal, HIV-Positive Women | | NCT00004400 |
| The effect and mechanism of the synergistic effect of estradiol and testosterone in postmenopausal osteoporosis | The effect and mechanism of the synergistic effect of estradiol and testosterone in postmenopausal osteoporosis | ChiCTR-OPC-16010120 |
| Evaluation of the effectiveness of herbal product on sexual dysfunction and testosterone levels of men undergoing methadone maintenance treatment | Evaluation of the effectiveness of herbal product on sexual dysfunction and testosterone levels of men undergoing methadone maintenance treatment (MMT) | IRCT20230805059047N1 |
| vitamin d intake in type 2 diabetic male patients: can it increase free testosterone?a clinical trial placebo -controlled (non active similar looking product as vitamin D) | Vitamin D Supplementation to increase free testosterone in Type 2 Diabetes Mellitus men: a Placebo-controlled Randomized Clinical Trial | EUCTR2018-001751-12-BE |
| Vitamin D and testosterone in men | A randomized, double-blind, placebo controlled trial to evaluate the effects of vitamin D supplementation on androgen levels in hypogonadal men - Vitamin D&TT | EUCTR2011-003575-11-AT |
| Effect of caffeine on Growth Hormone and Testosterone | The Effect of Caffeine Supplementation on Growth Hormone and Testosterone after Resistance Exercise According to the Polymorphism of Cytochrome P450 | IRCT20170405033231N2 |
| The Effect of Testosterone Supplementation on Rehabilitation Outcomes | The Effect of Testosterone Supplementation on Rehabilitation Outcomes | NCT00037999 |
| TOM: Testosterone in Older Men With Sarcopenia | Testosterone Replacement for Older Men With Sarcopenia | NCT00240981 |
| Effect of Transdermal Testosterone Replacement in Hypogonadal Men with either Metabolic Syndrome or Type 2 Diabetes Mellitus - TIMES 2 | Effect of Transdermal Testosterone Replacement in Hypogonadal Men with either Metabolic Syndrome or Type 2 Diabetes Mellitus - TIMES 2 | EUCTR2005-002607-17-GB |
| Efficacy and Safety of Androgel in the Treatment of Hypogonadal and Low Testosterone Men With Type 2 Diabetes | A Double Blind, Randomized, Placebo-Controlled, Parallel Study to Evaluate the Efficacy and Safety of Androgel, as an Adjunct to Hypoglycemic Therapy, in the Treatment of Hypogonadal and Low Testosterone Men With Type 2 Diabetes | NCT00141492 |
| Effect of Testosterone replacement on glycaemic control and insulin sensitivity in hypogonadal men with type 2 diabetes | | ISRCTN57267165 |
| NES Gel-1, To Evaluate Nestorone Gel in Combination With Testosterone Gel | A Randomized, Open Label Clinical Trial to Evaluate if Nestorone Gel Has Gonadotropin Suppressive Activity and if Nestorone in Combination With Testosterone Will Have an Additive Effect on Gonadotropin Suppression When Applied Transdermally in Healthy Men | NCT00229593 |
| A pharmacokinetic phase I study to assess the effect of different application sites on the pharmacokinetics of testosterone from a Testosterone Metered Dose (MD) Lotion in hypogonadism. | A pharmacokinetic phase I study to assess the effect of different application sites on the pharmacokinetics of testosterone from a Testosterone Metered Dose (MD) Lotion in hypogonadism. | ACTRN12605000518662 |
| A phase I pharmacokinetic study to compare the steady-state pharmacokinetics of testosterone following application of a Testosterone Metered-Dose Transdermal Spray (MDTS) to the forearm or abdomen in healthy postmenopausal women with low libido and low serum testosterone | A phase I pharmacokinetic study to compare the steady-state pharmacokinetics of testosterone following application of a Testosterone Metered-Dose Transdermal Spray (MDTS) to the forearm or abdomen in healthy postmenopausal women with low libido and low serum testosterone | ACTRN12605000522617 |
| A randomised, two-way crossover study to compare the pharmacokinetics of testosterone following application of a Testosterone Metered Dose (MD) lotion or AndroGel in men with low serum testosterone | A randomised, two-way crossover study to compare the pharmacokinetics of testosterone following application of a Testosterone Metered Dose (MD) lotion or AndroGel in men with low serum testosterone | ACTRN12605000517673 |
| A pharmacokinetic study to assess the effect of two different formulations of Testosterone Metered Dose (MD) Lotion on the pharmacokinetics of testosterone in hypogonadism | A pharmacokinetic study to assess the effect of two different formulations of Testosterone Metered Dose (MD) Lotion on the pharmacokinetics of testosterone in hypogonadism | ACTRN12605000528651 |
| A double-blind randomised placebo controlled study to evaluate the effects of different doses of testosterone from a Testosterone Metered-Dose Transdermal Spray (MDTS) on sexual function in premenopausal women with low libido | A double-blind randomised placebo controlled study to evaluate the effects of different doses of testosterone from a Testosterone Metered-Dose Transdermal Spray (MDTS) on sexual function in premenopausal women with low libido | ACTRN12605000481673 |
| How androgens exert their anabolic effects.Interaction of testosterone and growth hormone at the hepatic level. | How androgens exert their anabolic effects:Interaction of testosterone and growth hormone at the hepatic level in men with hypogonadism or hypopituitarism. | ACTRN12605000482662 |
| Assessment of Long Term Treatment With Testosterone Undecanoate in Males With Hypogonadism | Open One-arm Study to Investigate Safety and Efficacy of Intramuscular Injections of 1000 mg Testosterone Undecanoate (TU) in Hypogonadal Men at Variable Intervals During a 136-week to 192-week Treatment Including Pharmacokinetics | NCT00220298 |
| A Phase l Study to Determine the Pharmacokinetics of Testosterone from a Metered Dose Transdermal System (MDTS) in low libido in post-menopausal women suffering from low serum testosterome | A Phase l Study to Determine the Pharmacokinetics of Testosterone from a Metered Dose Transdermal System (MDTS) in low libido in post-menopausal women suffering from low serum testosterome | ACTRN12605000438651 |
| Double blind, placebo controlled randomized study of the effects of co-administering testosterone with PDE V inhibitor in ED patients non responders to PDE V inhibitors alone - TADTEST | Double blind, placebo controlled randomized study of the effects of co-administering testosterone with PDE V inhibitor in ED patients non responders to PDE V inhibitors alone - TADTEST | EUCTR2005-000852-34-FI |
| ANDRO 2002: Dehydroepiandrosterone (DHEA) or Testosterone Versus Placebo in Men With Sexual Dysfunction | A Randomized Double-Blind Placebo-Controlled Study Comparing the Safety and Efficacy of Dehydroepiandrosterone (DHEA) or Testosterone Versus Placebo in Men With Sexual Dysfunction | NCT00202163 |
| TRADE-Testosterone Replacement and Dutasteride Effectiveness | Testosterone Replacement and Dutasteride Effectiveness (TRADE) | NCT00194675 |
| Study of Transdermal Testosterone Patches in Menopausal Women With Low Libido | A Randomized, Double-Blind, Placebo-controlled, Parallel-group, 52-week Study to Evaluate the Efficacy/Safety of Transdermal Patches Delivering Testosterone in Menopausal Women With Low Libido Not Receiving Estrogen Therapy | NCT00131495 |
| Testosterone Effects on Bone and Frailty | Testosterone Effects on Bone and Frailty in Men With Osteoporosis | NCT00182871 |
| Three-Year Trial on a New Testosterone Gel | Three-Year Trial on a New Testosterone Gel: Clinical Efficacy, Tolerability and Compliance | NCT00204269 |
| Study of The Effects of Testosterone in Frail Elderly Men | Study of The Effects of Testosterone on Muscle Function, Physical Performance, Body Composition and Quality of Life in Frail Elderly Men | NCT00190060 |
| Observation Study of T-Gel (1%) in Treatment of Adolescent Boys With Hypogonadism | A Multi-Center, Open-Label, Observational Study of Testosterone Gel (1%) in the Treatment of Adolescent Boys With Hypogonadism | NCT00193661 |
| Pharmacokinetic Evaluation of Testosterone Gel (1%) | Pharmacokinetic Evaluation of Testosterone Gel (1%) in Prepubertal Boys of Adolescent Age | NCT00193700 |
| Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone (HOP 5) Testicular Aspiration Addendum | Male Hormonal Contraception Development: Suppression of Spermatogenesis With the Addition of a Potent GnRH Antagonist (Acyline) to Testosterone and DMPA (ACY-5) -Sub-Study (HOP 5) | NCT00156650 |
| Oral Androgens in Man-3 (ORAL T-3) Pharmacokinetics of Oral Testosterone | Oral Androgens in Man-3: Pharmacokinetics of Oral Testosterone With Concomitant Inhibition of 5a-Reductase by Dutasteride Short Title: ORAL T-3 | NCT00161421 |
| The Effects of Testosterone on Prostate Tissue (ACYP-1) | The Effects of Testosterone on Prostate Tissue in Normal Men (ACYP-1) | NCT00161486 |
| Male Hormonal Contraceptive Development-ACY-5 | Male Hormonal Contraceptive Development: Suppression of Spermatogenesis With the Addition of a Potent Antagonist (Acyline) to Testosterone and DMPA (ACY-5) | NCT00161447 |
| Study to Determine the Effects of Testosterone Replacement Therapy in Aging Men With Androgen Deficiency | Effects of Testosterone Administration on Tissues of Men With A.D.A.M. (Androgen Deficiency of Aging Men) | NCT00161304 |
| Testosterone in Obese Men Trial | A 12-month Randomised, Placebo-controlled Trial of Testosterone Replacement Therapy and Lifestyle Modification Versus Lifestyle Modification Alone on Visceral Adiposity and Markers of Cardiovascular Risk in Obese Middle-Aged and Older Men | ACTRN12605000283673 |
| Testosterone and Its Metabolites in GID | Role of Testosterone and Its Metabolites Regarding Different Physiological Functions in Subjects Affected by Gender Identity Disorder (FtM Transsexuals) | NCT00146146 |
| Testosterone Gel Applied to Women With Pituitary Gland Problems | Physiologic Testosterone Replacement in Women With Hypopituitarism | NCT00144391 |
| Testosterone in Female Hypoactive Sexual Desire Disorder | Transdermal Testosterone Gel Prn Application for Hypoactive Sexual Desire Disorder in Women: A Controlled Study | NCT00140153 |
| The Effect of Testosterone on Mood and Quality of Life | The Effect of Testosterone Treatment on Depressive Symptoms and Quality of Life in Older Men With Age-Related Hypogonadism and Subsyndromal Depression. | NCT00202462 |
| Testosterone Replacement Therapy in Advanced Chronic Kidney Disease | Testosterone Replacement Therapy in Advanced Chronic Kidney Disease | NCT00645658 |
| Testosterone in Castration-Resistant Prostate Cancer | Testosterone Replacement Therapy in Castration-Resistant Prostate Cancer | NCT00577980 |
| ORAL T-6: Oral Androgens in Man-6 | Oral Androgens in Man-6: Pharmacokinetics of Slow and Fast Release, External Matrix Oral Testosterone Formulations in Normal Men With Experimental Hypogonadism | NCT00663793 |
| A phase I open-label, balanced, randomized, crossover, three-groups, three-treatments, three-period, pharmacokinetic study of intranasal testosterone gel administration to healthy, adult, male subjects | A phase I open-label, balanced, randomized, crossover, three-groups, three-treatments, three-period, pharmacokinetic study of intranasal testosterone gel administration to healthy, adult, male subjects - Comparison of three intranasal testosterone gel formulations | NL-OMON36048 |
| The role of testosterone in social decision-making - An exploratory investigation into the effects of testosterone on human brain and behavior | The role of testosterone in social decision-making - An exploratory investigation into the effects of testosterone on human brain and behavior - The role of testosterone in social decision-making | NL-OMON36724 |
| PROS-2 Dose Response Effects of Exogenous Testosterone on the Prostate | Dose Response Effects of Exogenous Testosterone on the Prostate and Comparison With Effects on Body Composition (Short Title: PROS-2) | NCT01327495 |
| Pharmacokinetics, Metabolism, Efficacy, and Safety Study of Two Testosterone Matrix Transdermal Systems | An Open Label, Dose-Proportionality, Bioavailability and Dose- Titration Investigation of the Pharmacokinetics, Metabolism, Efficacy and Safety of Two Testosterone Matrix Transdermal Systems (28 cm2 and 48 cm2) in Hypogonadal Men | NCT01323140 |
| A phase-I open label, balanced, randomized, crossover, two-groups, two-treatments, two-period, pilot study in healthy male subjects to determine the feasibility of a multiple dose dispenser for testosterone intranasal gel as measured by pharmacokinetics | A phase-I open label, balanced, randomized, crossover, two-groups, two-treatments, two-period, pilot study in healthy male subjects to determine the feasibility of a multiple dose dispenser for testosterone intranasal gel as measured by pharmacokinetics - Testosterone nasal gel using dispenser or syringe in healthy volunteers | NL-OMON36214 |
| A randomized, cross-over controlled study to compare the pharmacokinetic profiles of sublingual administered testosterone solution followed by a sildenafil citrate tablet, versus sublingual testosterone and sildenafil citrate combined in one tablet in healthy premenopausal women | A randomized, cross-over controlled study to compare the pharmacokinetic profiles of sublingual administered testosterone solution followed by a sildenafil citrate tablet, versus sublingual testosterone and sildenafil citrate combined in one tablet in healthy premenopausal women - PK - Lybrido Formulations 1 and 2 | NL-OMON36050 |
| Efficacy of Luteinizing Hormone (LH) Activity in Low Responder Patients With Transdermal Testosterone | Efficacy of LH Activity in Low Responder Patients With Transdermal Testosterone: a Randomised Controlled Study. | NCT01291212 |
| Normalization of Morning Testosterone Levels in Men With Secondary Hypogonadism | A Randomized, Double Blind, Placebo and Active Controlled, Parallel, Multi-Center Phase IIb Study to Evaluate Normalization of Morning Testosterone Levels in Men With Secondary Hypogonadism | NCT01270841 |
| Cardiovascular Outcomes of Replacement with Testosterone. Role of testosterone replacement therapy in patients with heart failure. - CORTe | Cardiovascular Outcomes of Replacement with Testosterone. Role of testosterone replacement therapy in patients with heart failure. - CORTe | EUCTR2010-022821-14-IT |
| Transdermal testosterone therapy: a potential treatment for selective serotonin reuptake inhibitor (SSRI)-associated sexual dysfunction in women. | Transdermal testosterone therapy: A potential treatment for selective serotonin reuptake inhibitor (SSRI) - associated sexual dysfunction in women being treated for depression | ACTRN12610001079033 |
| Efficacy of an Intranasal Testosterone Product | An Open Label, Randomized, Balanced, Three Treatment, Parallel Design, Pharmacokinetic Study of Intranasal TBS-1 Administration to Hypogonadal Men | NCT01252745 |
| Time to Eugonadal Range, Time to Steady State and Drying Time | Assessment of Time to Eugonadal Testosterone Range After Initial Fortesta (Testosterone) Gel 2% Application, Time to Steady State After Initiation of Fortesta, And Gel Drying Time After Fortesta Application | NCT01228071 |
| Testosterone Patch's Effects on the Cardiovascular System and Libido | Pilot Study: Evaluating the Effect of 300 Micrograms Testosterone Patches in Addition to Hormone Replacement Therapy on Arterial Compliance, Insulin Resistance and Sexual Desire. | NCT01208038 |
| Hormone Treatment in Growth Hormone and Testosterone Deficient Patients | Growth Hormone and Gonadotropin Deficiency After Brain Injury (Traumatic Brain Injury, Subarachnoidal Hemorrhage, Ischemic Stroke): the Effects of Hormone Replacement on Cognition, Quality of Life and Body Composition | NCT01397500 |
| Neuroendocrine Dysfunction in Traumatic Brain Injury: Effects of Testosterone Therapy | Neuroendocrine Dysfunction in Traumatic Brain Injury: Effects of Testosterone Therapy | NCT01201863 |
| Effect of Varying Testosterone Levels on Insulin Sensitivity in Men With Idiopathic Hypogonadotropic Hypogonadism (IHH) | Effect of Varying Testosterone Levels on Insulin Sensitivity in Men With Idiopathic Hypogonadotropic Hypogonadism | NCT03118479 |
| Hypogonadism in Young Men With Type 2 Diabetes | Effect of Hypogonadotropic Hypogonadism and Replacement With Clomiphene Citrate and Testosterone on Insulin Sensitivity, Body Composition, Inflammation, Sexual Function and Spermatogenesis in Young Type 2 Diabetic Men | NCT01155518 |
| ESPRIT Study in Hypogonadal Men | Energy, Sexual Desire and Body PropoRtions wIth AndroGel®, Testosterone 1% Gel Therapy (ESPRIT) in Hypogonadal Men | NCT01143818 |
| Hair Cortisol and Testosterone Levels in Patients With and Without Acute Myocardial Infarction(MI) | A Comparison of Hair Cortisol and Testosterone Levels in Patients With Acute MI and Controls With and Without Chronic Cardiovascular Disease or Diabetes | NCT01144065 |
| An Open-Label Study of Serum Testosterone Levels in Non-dosed Females After Secondary Exposure to Testosterone Gel 1.62% Applied to the Upper Arms and Shoulders and Use of a T-shirt Barrier | An Open-Label Study of Serum Testosterone Levels in Non-dosed Females After Secondary Exposure to Testosterone Gel 1.62% Applied to the Upper Arms and Shoulders and Use of a T-shirt Barrier | NCT01130298 |
| Pharmacokinetic and Comparative Bioavailability Study of Testosterone Absorption After Administration of Testosterone Gel 1.62% to the Upper Arms/Shoulders Using an Application Site Rotation or a Combination of Application Sites in Hypogonadal Males | A Multiple Dose Pharmacokinetic and Comparative Bioavailability Study of Testosterone Absorption After Administration of 5 g Testosterone Gel 1.62% to the Upper Arms/Shoulders Using an Application Site Rotation or a Combination of Application Sites in Hypogonadal Males | NCT01133548 |
| Testosterone Replacement in Men With Diabetes and Obesity | Effect of Hypogonadotrophic Hypogonadism and Treatment With Testosterone on Insulin Sensitivity, Inflammation, Body Composition and Sexual Function in Obese and Type 2 Diabetic Men | NCT01127659 |
| A study to investigate the pharmacokinetic profile of 3 doses of sublingual testosterone solution and their effect on physiological and subjective arousal in healthy, sexually functional premenopausal women. | PK-PD Testosterone: An investigator blind, randomized, cross-over placebo controlled dose finding study to investigate the pharmacokinetic profile of 3 doses of sublingual testosterone solution and their effect on physiological and subjective arousal in healthy, sexually functional premenopausal women. | NL-OMON21403 |
| Vaginal Testosterone Cream For Atrophic Vaginitis in Women Taking Aromatase Inhibitors for Breast Cancer. | Vaginal Testosterone Cream For Atrophic Vaginitis in Women Taking Aromatase Inhibitors for Breast Cancer. | NCT01122342 |
| Testosterone Replacement in Metabolic Syndrome and Inflammation | Testosterone Replacement in Metabolic Syndrome and Inflammation of Fat Tissue | NCT01123278 |
| The effect of testosterone and a nutritional supplement on hospital admissions in under-nourished, older people. | The effect of testosterone and a nutritional supplement on hospital admissions in under-nourished, older people. | ACTRN12610000356066 |
| The effect of testosterone replacement on metabolism and QOL of the male patients with secondary hypogonadism | The effect of testosterone replacement on metabolism and QOL of the male patients with secondary hypogonadism - The effect of testosterone replacement on metabolism and QOL of the male patients with secondary hypogonadism | JPRN-UMIN000003501 |
| A Pharmacokinetic (PK) Study to Compare the Absorption of Two Formulations of Transdermal Testosterone Spray and Intrinsa® | A Phase 1, Open-label, Randomized, Three-cohort, Two-period Crossover Study to Determine the Relative Bioavailability of Testosterone Following Application of Two Testosterone Transdermal Spray (TTS) Formulations Once Daily and Intrinsa® Patch Twice Weekly in Healthy, Surgically and Naturally Post-menopausal Women Receiving Estrogen Replacement Therapy | NCT01096329 |
| ORAL T-8 Oral Testosterone for Male Hormonal Contraception | Pharmacokinetics of Modified Slow-Release Oral Testosterone Over 10 Days in Normal Men With Experimental Hypogonadism | NCT01167829 |
| Testosterone replacement in young male cancer survivors | Testosterone Replacement in Young Male cancer Survivors: a prospective, multicentre, randomised, double-blinded, parallel-group, placebo-controlled phase III trial | ISRCTN70274195 |
| Effect of testosterone on androgen deficiency | Evaluation of therapeutic effect of long acting testosterone ampule in Patients with androgen deficiency syndrome presented at urology clinics of Ahwaz. | IRCT201104236258N1 |
| PK Study of Testosterone Nasal Gel (TBS-2) in Healthy Premenopausal Women | An Open-label, Single and Multiple Application of Intranasal Testosterone Gel (TBS-2) in Healthy Premenopausal Female Subjects at Three Dose Levels | NCT01364623 |
| Testosterone Administration and ACL Reconstruction in Men | The Effects of Acute Testosterone Administration in Men on Muscle Mass, Strength, and Physical Function Following ACL Reconstructive Surgery | NCT01595581 |
| Testosterone in Treating Postmenopausal Patients With Arthralgia Caused by Adjuvant Aromatase Inhibitor Treatment | Randomized Double-Blind Placebo Controlled Study of Testosterone in the Adjuvant Treatment of Postmenopausal Women With Aromatase Inhibitor Induced Arthralgias | NCT01573442 |
| Effects of tesstosterone( male hormone) on glucose control and cardiovascular risk factors in men with type 2 diabetes | “Effects of testosterone on glycaemic control and other Cardiovascular Risk factors in Hypogonadal Men with uncontrolled Type 2 Diabetes: A randomized double – blinded placebo controlled add on trial using depot testosterone undecanoate” - Testosterone and glycaemic control in hypogonadal men. Version 1 | EUCTR2011-006114-14-GB |
| Study of Psychological and Motor Effects of Testosterone in Adolescents With XXY/Klinefelter Syndrome | Psychological and Motor Effects of Testosterone Therapy in Adolescents With XXY/Klinefelter Syndrome | NCT01585831 |
| Steroid Profile: Differentiating Testosterone Administration From (Simultaneous) Ethanol Consumption | Steroid Profile: Differentiating Testosterone Administration From (Simultaneous) Ethanol Consumption: Evaluation of Newly Developed Markers | NCT04166786 |
| A 2-year, multi-centre double-blind, randomised, placebo-controlled trial to determine in men with total testosterone equal to or less than 14nmol/L the efficacy of testosterone treatment together with a lifestyle program in comparison to a lifestyle program alone, to normalise glucose tolerance in those with newly diagnosed type 2 diabetes (T2DM) or prevent progression to T2DM in those with pre-diabetes. | Will testosterone treatment in combination with a lifestyle program normalise glucose tolerance in men with either pre-diabetes or newly diagnosed type 2 diabetes, in comparison to placebo and a lifestyle program? | ACTRN12612000287831 |
| Effects of Testosterone and Oestradiol Therapy on Clinical Indices and Biomarkers of Dry Eye in Post Menopausal Women | In post menopausal women, does administration of Estradot 50mcg patches twice weekly and/or Andro-Feme cream, 1/2ml daily, for eight weeks, compared to placebo improve dry eye clinical indices and biomarkers | ACTRN12612000281897 |
| Testosterone Replacement in Postmenopausal Women With Stress Urinary Incontinence | Testosterone Replacement in Postmenopausal Women With Stress Urinary Incontinence | NCT03116087 |
| Oral Testosterone for Fatigue in Male Multiple Sclerosis Patients | A Randomized, Controlled Crossover Trial Evaluating Oral Testosterone in the Treatment of Fatigue in Male Multiple Sclerosis Patients | NCT01516554 |
| Testosterone therapy of patients with type 2 diabetes mellitus | Testosterone therapy of patients with type 2 diabetes mellitus - Testosterone therapy of patients with type 2 diabetes mellitus | EUCTR2011-002102-73-DK |
| The Effect of Testosterone Replacement on Endothelial Dysfunction, Inflammation and Insulin Resistance in Male Hypogonadotrophic Hypogonadism | Phase 4 Study That Evaluates the Effects of Two Different Testosterone Replacement Regiments on Endothelial Dysfunction, Inflammation and Insulin Resistance in Male Subjects With Hypogonadotrophic Hypogonadism. | NCT01533129 |
| Effect of testosterone in male patients on regular hemodialysis | A randomised, double-blind study to investigate the effects of intramuscular testosterone undecanoate (Nebido®) on anemia treatment in testosterone deficient men undergoing hemodialysis. - DiaTest | EUCTR2011-005439-20-SE |
| The VO2 Increase With Testosterone Addition - Heart Failure (VITA-HF) Trial | The VO2 Increase With Testosterone Addition - Heart Failure (VITA-HF) Trial | NCT01469988 |
| A Clinical Study to Evaluate the Pharmacokinetics of Testosterone Gel Using an Applicator | A Phase 2, Open-Label, Sequential Dose Escalation Study in Adult Hypogonadal Males to Evaluate the Pharmacokinetics of Three Volumes of FE 999303 (Testosterone Gel), Applied to the Shoulder/Upper Arm, Using an Applicator Compared With Hand Application | NCT01464879 |
| Male sex hormone therapy to young males with hormone deficiency: 2 years, double-bld, placebo controlled study | Androgen replacement in young hypogonadal men: a 2 year randomized, double-blind placebo controlled study - Testosterone replacement | EUCTR2011-004266-15-SE |
| Testosterone and Alendronate in Hypogonadal Men | Testosterone and Alendronate in Hypogonadal Men | NCT01460654 |
| The Effect of Testosterone Replacement on the High Density Lipoprotein Cholesterol Subgroups | Phase 4 Study That Compares the High Density Lipoprotein Cholesterol (HDL) Cholesterol Subgroups of the Patients With Congenital Hypogonadotrophic Hypogonadism With That of the Healthy Control Subjects, and Investigates the Effect of Testosterone Treatment on HDL Subgroups. | NCT01454011 |
| A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels | A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Explore the Impact of Testosterone Solution 2% on Symptoms of Ejaculatory Dysfunction in Men With Testosterone Deficiency | NCT01419236 |
| Administration study to healthy adult female as part of reserach toward the development of detection method for testosterone doping | Administration study to healthy adult female as part of reserach toward the development of detection method for testosterone doping | JPRN-jRCT1080221545 |
| Not applicable | PHASE III, ACTIVE-CONTROLLED, SAFETY AND EFFICACY TRIAL OF ORAL TESTOSTERONE UNDECANOATE (TU) IN HYPOGONADAL MEN. | EUCTR2011-001638-41-DE |
| The Effects of Long Term Cyclic Testosterone Administration on Muscle Function and Bone in Older Men | The Effects of Long Term Cyclic Testosterone Administration on Muscle Function and Bone in Older Men | NCT01417364 |
| Comparison of clinical and metabolic effects of testosterone and estradiol in adult gonadectomized patients with normal male chromosome set and Disorder of Sex Developement due to complete androgen insensitivity syndrome (CAIS) | Comparison of clinical and metabolic effects of testosterone and estradiol in adult gonadectomized patients with 46,XY DSD due to complete androgen insensitivity syndrome (CAIS) - CAIS | EUCTR2010-021790-37-DE |
| Study on the Effects of Exogenous Testosterone on Threat Perception and Behavioral Avoidance | Study on the Effects of Exogenous Testosterone on Threat Perception and Behavioral Avoidance | NCT01408498 |
| Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men | Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men | NCT01403116 |
| A One Year Open Label Study for the Treatment of Hypogonadism (Low Testosterone) in Men Who Have Completed ZA-203 | A One Year Open Label Study of Androxal in the Treatment of Secondary Hypogonadism in Men Who Have Completed Protocol ZA-203 | NCT01386567 |
| The Effect on Androxal Versus Androgel on Morning Testosterone in Men With Secondary Hypogonadism (Low Testosterone) | A Randomized, Single Blind, Multi-Center Phase II Study to Evaluate the Effect of Three Different Doses of Androxal and AndroGel on 24-Hour Luteinizing Hormone and Testosterone in Normal Healthy Men | NCT01386606 |
| A double-blind, randomized, placebo-controlled, proof of concept study to investigate the safety and efficacy of the combined administration of 0.5 mg sublingual testosterone and 10 mg tadalafil in women with hypoactive sexual desire disorder | A double-blind, randomized, placebo-controlled, proof of concept study to investigate the safety and efficacy of the combined administration of 0.5 mg sublingual testosterone and 10 mg tadalafil in women with hypoactive sexual desire disorder - Tadalafil Proof of Concept | NL-OMON36064 |
| CYP19A1 (Cytochrome P450 Family 19 Subfamily A Member 1) Gene and Pharmacogenetics of Response to Testosterone Therapy | CYP19A1 Gene and Pharmacogenetics of Response | NCT01378299 |
| Efficacy, Pharmacokinetics and Safety of Testosterone | A Phase 2 Open-Label, Sequential Dose Escalation Study to Evaluate the Efficacy, Pharmacokinetics and Safety of Three Volumes (1.25, 2.50 and 3.75 mL) of Testosterone Gel 2% (FE 999303) Equivalent to 23, 46 And 70 mg of Testosterone in Hypogonadal Males | NCT01370369 |
| NASOBOL in Hypogonadal Men in Comparison to Testosterone Levels in Normal Healthy Male Volunteers | A Multiple Dose, Pharmacokinetic Study Comparing Different Regimens of Testosterone Given as Intranasal NASOBOL® in Hypogonadal Men in Comparison to Testosterone Levels in Normal Healthy Male Volunteers | NCT00647868 |
| Effect of exercise alone or in combination with testosterone replacement on muscle strength and quality of life in older men with low testosterone concentrations: a randomized double-blind, placebo controlled study | Effect of exercise alone or in combination with testosterone replacement on muscle strength and quality of life in older men with low testosterone concentrations: a randomized double-blind, placebo controlled study | EUCTR2009-017139-16-DE |
| Study of Testosterone and Athlete Response | Effects of Moderately Increased Testosterone Concentration on Physical Performance and Behaviour in Healthy Women - a Double-blind, Randomized, Placebo-controlled Study | NCT03210558 |
| Assessing the Safety/Efficacy of Transdermal Testosterone in Female Patients With Symptomatic Heart Failure | A Placebo-controlled Study to Determine the Efficacy and Safety of 300 and 450 µg/Day Transdermal Testosterone in Female Patients With Low Ejection Fraction and Symptomatic Heart Failure | NCT00957034 |
| Metabolic Effects of Steroids in Obese Men | Metabolic Effects of Testosterone Alone or in Combination With Dutasteride or Anastrazole in Obese Men | NCT00983554 |
| Safety and Efficacy Study of a Testosterone Eye Drop for the Treatment of Meibomian Gland Dysfunction | A Single-Center, Double-Masked, Randomized, Vehicle Controlled Study to Evaluate the Safety and Efficacy of Testosterone 0.03% Ophthalmic Solution Compared to Vehicle for the Treatment of Meibomian Gland Dysfunction | NCT00755183 |
| Pilot Study: Evaluating the effect of 300microgram testosterone patches in addition to Hormone Replacement Therapy on arterial compliance, insulin resistance and sexual desire - Testosterone Patch's effects on cardiovascular system & libido (pilot) | Pilot Study: Evaluating the effect of 300microgram testosterone patches in addition to Hormone Replacement Therapy on arterial compliance, insulin resistance and sexual desire - Testosterone Patch's effects on cardiovascular system & libido (pilot) | EUCTR2009-013275-21-GB |
| Bioequivalence of Testosterone Reduced-size Patch Relative to the Testosterone Reference Patch | An Open-label, Multiple-dose, Randomized, Two-period Crossover Study to Assess Bioequivalence of the 300 Mcg/Day Testosterone Reduced-size Patch (14 cm2) Relative to the 300 Mcg/Day Testosterone Reference Patch (28 cm2) | NCT00791856 |
| A Study to Investigate Biomarkers of Skin Androgenization Following Testosterone Administration (0000-015)(COMPLETED). | A Pilot Study to Investigate Biomarkers of Skin Androgenization Following Short-Term Testosterone Administration in Healthy Postmenopausal Women | NCT00969163 |
| The Testosterone Trials in Older Men | Randomized, Placebo-controlled, Double-blind Study of Seven Coordinated Testosterone Treatment Trials in Older Men | NCT00799617 |
| Testosterone Replacement for Fatigue in Male Hypogonadic Advanced Cancer Patients | A Preliminary Trial of Testosterone Replacement for Fatigue in Male Hypogonadic Patients With Advanced Cancer. | NCT00965341 |
| A Study to Evaluate the Effect of Testosterone on Muscle Fractional Synthetic Rate (MK-0000-064) | A Randomized, Single-Blind, Placebo-Controlled, Single-dose, Parallel Design Study to Evaluate the Effect of Testosterone on Muscle Fractional Synthetic Rate (FSR) | NCT00816712 |
| Anabolic and Inflammatory Responses to Short-Term Testosterone Administration in Older Men | Anabolic and Inflammatory Responses to Short-Term Testosterone Administration in Older Men | NCT00957801 |
| HOP-3 Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone | Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone (Short Title (HOP-3) | NCT00839319 |
| Cycled Testosterone Replacement Study | The Effects of Cyclic Testosterone Administration on Muscle Function in Older Individuals | NCT00957528 |
| A clinical trial to study the contraceptive efficacy of two drugs, norethisterone enatate and testosterone undecanoate in healthy men | Sperm suppression and contraceptive protection provided by norethisterone enatate (NET-EN) combined with testosterone undecanate (TU) in healthy men | CTRI/2010/091/000225 |
| Exogenous Testosterone Plus Dutasteride for the Treatment of Castrate Metastatic Prostate Cancer | Phase II Trial of Exogenous Testosterone Plus Dutasteride for the Treatment of Castrate Metastatic Prostate Cancer | NCT00853697 |
| Study to Determine the Effect of Food on the Absorption of an Oral Testosterone Undecanoate Formulation | Phase II Study of the Effect of Food With Various Levels of Fat on the Pharmacokinetics of an Oral Testosterone Undecanoate Formulation in Hypogonadal Men | NCT00924612 |
| The Effect of Testosterone Replacement on Bone Mineral Density in Boys and Men With Anorexia Nervosa | The Effect of Testosterone Replacement on Bone Mineral Density and Bone Microarchitecture in Teenage Boys and Young Adult Men With Anorexia Nervosa | NCT00853502 |
| Pharmacokinetic Study to Determine Time to Steady-state | Pharmacokinetic Study to Determine Time to Steady-state of an Oral Testosterone Undecanoate Formulation in Hypogonadal Men. | NCT00911586 |
| Study of the Safety, and Sperm and Gonadotropin Suppression of a Contraceptive Gel in Normal Men | A Multicenter, Randomized, Double-Blind Comparator Trial of the Safety and Sperm and Gonadotropin Suppression Resulting From Combined Use of Nestorone® Gel (0, 8 or 12 mg NES) and Testosterone Gel (10 g) Compared With Testosterone Gel in Normal Men | NCT00891228 |
| A Study of the Pharmacokinetics of Testosterone Metered Dose (MD)-Lotion Formulations | A Phase II, Randomised, Four-way Crossover Study to Compare the Steady State Pharmacokinetics of Testosterone Following Application of Different Testosterone Metered Dose (MD) Lotion® Formulations and Doses in Hypogonadal Men | NCT00857961 |
| Testosterone for Treating Cachexia in Patients With Squamous Cell Carcinoma | Nutrition and Anabolic Interventions in Squamous Cell Carcinoma | NCT00878995 |
| A Phase II open-label pilot study to assess the effects of Testosterone Metered Dose Transdermal System (MDTS) administration on cognitive function in women | A Phase II open-label pilot study to assess the effects of Testosterone Metered Dose Transdermal System (MDTS) administration on cognitive function in women | ACTRN12608000429358 |
| A Trial to Evaluate the Ongoing Skin Safety of Testosterone MD-Lotion Formulations | A Phase III Open-label Extension of the MTE08 Trial (A Phase III Open-label Titration Trial to Evaluate the Effectiveness and Safety of Different Doses of a Dermal Application of Testosterone MD-Lotion® (Cutaneous Solution) in Hypogonadal Men) to Evaluate Skin-safety | NCT00857454 |
| Testosterone MD-Lotion Residual Washing Study | A Healthy Volunteer, Single Dose Phase I Trial to Determine the Amount of Testerone MD-Lotion 2% Remaining on the Axilla After Washing. | NCT00996151 |
| Study of Serum Testosterone Levels in Non-dosed Females After Secondary Exposure | An Open-label Study of Serum Testosterone Levels in Non-dosed Females After Secondary Exposure to Testosterone Gel 1.62% | NCT00998933 |
| Effects of Testosterone in Women With Depression | Effects of Testosterone in Women With Depression: A Pilot Study | NCT00676676 |
| A double blind, randomized, cross-over placebo controlled study to investigate the efficacy of sublingual testosterone solution on physiological and subjective arousal in healthy, sexually dysfunctional premenopausal women. - PD testosterone | A double blind, randomized, cross-over placebo controlled study to investigate the efficacy of sublingual testosterone solution on physiological and subjective arousal in healthy, sexually dysfunctional premenopausal women. - PD testosterone | EUCTR2010-019540-39-NL |
| A randomised, placebo controlled, double blind study to evaluate the effect of 300mcg testosterone patches in addition to HRT on arterial compliance, insulin resistance and sexual desire. - Testosterone Patch's effect on the Cardiovascular system and libido. | A randomised, placebo controlled, double blind study to evaluate the effect of 300mcg testosterone patches in addition to HRT on arterial compliance, insulin resistance and sexual desire. - Testosterone Patch's effect on the Cardiovascular system and libido. | EUCTR2007-005911-25-GB |
| Androgens for Poor Responders in In Vitro Fertilization | Transdermal Testosterone to Improve Ovarian Response to Gonadotropins in Poor Responder IVF Patients With Normal Basal Concentrations of FSH | NCT00693108 |
| A Pilot Study of Parenteral Testosterone and Oral Etoposide as Therapy for Men With Castration Resistant Prostate Cancer | A Pilot Study of Parenteral Testosterone and Oral Etoposide as Therapy for Men With Castration Resistant Prostate Cancer | NCT01084759 |
| Pharmacokinetic Study of Oral Testosterone (T) Ester Formulations in Hypogonadal Men | Phase II, Repeat Dose, Pharmacokinetic Study of Oral Testosterone Ester Formulations in Hypogonadal Men | NCT00695110 |
| Effect of Testosterone on Endothelial Function and Microcirculation in Type 2 Diabetic Patients With Hypogonadism | Phase IV: Effect of Testosterone on Endothelial Function and Microcirculation in Type 2 Diabetic Patients With Hypogonadism | NCT01084369 |
| Vaginal Testosterone Cream vs ESTRING for Vaginal Dryness or Decreased Libido in Early Stage Breast Cancer Patients | A Phase II Study of Vaginal Testosterone Cream vs. the ESTRING for Vaginal Dryness or Decreased Libido in Early Breast Cancer Patients Treated With Aromatase Inhibitors | NCT00698035 |
| A single blind, randomized, cross-over placebo controlled dose finding study to investigate the pharmacokinetic profile of 3 doses of sublingual testosterone solution and their effect on physiological and subjective arousal in healthy, sexually functional premenopausal women. - PK-PD testosterone | A single blind, randomized, cross-over placebo controlled dose finding study to investigate the pharmacokinetic profile of 3 doses of sublingual testosterone solution and their effect on physiological and subjective arousal in healthy, sexually functional premenopausal women. - PK-PD testosterone | EUCTR2010-019285-86-NL |
| To Determine the Effects of Deodorant, Antiperspirant and Washing on the Pharmacokinetics of 2% Testosterone MD Lotion | A Phase I Trial to Determine the Impact of Application of Antiperspirant and Deodorant as Well as Washing the Application Site, on the Pharmacokinetics of Testosterone Following Single Dose Applications of 2% Testosterone MD-Lotion® (Cutaneous Solution) | NCT00857168 |
| The effect of transdermal testosterone patch (Intrinsa registered trademark) on cognitive performance in older postmenopausal women: a randomized placebo controlled trial over 26 weeks. | The effect of transdermal testosterone patch (Intrinsa registered trademark) on cognitive performance in older postmenopausal women: a randomized placebo controlled trial over 26 weeks. | ACTRN12610000029099 |
| The Effect of IM Testosterone Undecanoate on Biochemical and Anthropometric Characteristics of Metabolic Syndrome in Hypogonadal Men | A Randomized, Placebo-Controlled, Double-Blind, Parallel Group Study With Open-Label Follow-up to Investigate the Effect of IM Testosterone Undecanoate on Biochemical and Anthropometric Characteristics of Metabolic Syndrome in Hypogonadal Men | NCT00696748 |
| A Phase III open-label titration trial to evaluate the effectiveness and safety of different doses of a dermal application of Testosterone MD-Lotion® (cutaneous solution) in hypogonadal men | A Phase III open-label titration trial to evaluate the effectiveness and safety of different doses of a dermal application of Testosterone MD-Lotion® (cutaneous solution) in hypogonadal men | EUCTR2008-001060-36-GB |
| Treatment of Testosterone deficiency in men with Sleep Apnoea Syndrome utilising Nebido therapy. - | EUCTR2008-001459-23-GB |
| A Titration Trial to Determine the Effectiveness of Testosterone MD-Lotion (Cutaneous Solution) Formulations | A Phase III Open-label Titration Trial to Evaluate the Effectiveness and Safety of Different Doses of a Dermal Application of Testosterone MD-Lotion® (Cutaneous Solution) in Hypogonadal Men | NCT00702650 |
| Influence of Administration Route of Testosterone on Male Fertility | Influence on Human Male Fertility of Testosterone After Intranasal (MPP10) or Transdermal (AndroGel™) Application | NCT00705796 |
| The effect of transdermal testosterone gel300mcg daily on cognitive performance in older postmenopausal women: a placebo controlled trial over 26 weeks | The effect of transdermal testosterone gel300mcg daily on cognitive performance in older postmenopausal women: a placebo controlled trial over 26 weeks | ACTRN12609000981224 |
| ROLE OF TESTOSTERONE AND ITS METABOLITE DIHYDROTESTOSTERONE ON METABOLISM AND ON MUSCLE STRENGTH IN SUBJECTS AFFECTED BY GENEDER IDENTITY DISORDER (GID) (FtM TRANSSEXUALS) - ND | ROLE OF TESTOSTERONE AND ITS METABOLITE DIHYDROTESTOSTERONE ON METABOLISM AND ON MUSCLE STRENGTH IN SUBJECTS AFFECTED BY GENEDER IDENTITY DISORDER (GID) (FtM TRANSSEXUALS) - ND | EUCTR2008-003251-74-IT |
